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A clinician’s assessment of pain conditions relies on a patient’s self-reported 
measures of pain and discomfort. Moreover, very little is known about the detailed 
changes in pain intensity and distribution between consultations. Momentary 
assessment of pain can mitigate recall bias and prove advantageous towards the 
management of pain. However, easily quantifiable measures of momentary pain are 
limited. The development of digital health technologies can help to overcome and 
improve these limitations as well as creating new opportunities to dive deeper into 
the mechanisms of pain. 
The aim of this PhD project was to assess spatiotemporal changes of self-reported 
pain intensity and distribution (extent and location) in experimental and clinical 
pain, using state-of-the-art digital pain mapping technology. The objectives of this 
PhD were (1) to acquire and quantify changes of momentary pain and discomfort 
intensity and distribution over time, and (2) to assess the advantages, limitations, 
and barriers of use of the pain mapping technology. 
This PhD project utilized patients with musculoskeletal chronic spinally referred 
pain, as well as two different models to induce pain and discomfort in healthy 
participants. Patients with chronic pain mapped and tracked their pain intensity and 
distribution over time. A well-established experimental pain model was used to 
induce transient acute musculoskeletal low-back pain and aimed to assess dose-
response differences in evoked intensity and extent over time. A second model 
induced experimental discomfort and aimed to explore changes in perception.  
The first study demonstrated and characterized dose-response differences in saline-
evoked spatiotemporal pain intensity and distribution over time, supporting the 
relevance of repeated momentary pain assessment. The second study revealed 
previously unseen fluctuations in pain intensity and extent over a prolonged period, 
in patients with spinally referred pain. Additionally, results revealed patients’ 
characteristics and barriers of use that influenced reporting compliance. Finally, the 
third study supported the use of modifiable animations to assist with the 
quantification of real-time changes in quality descriptors.  
In conclusion, the current PhD thesis provides evidence of spatiotemporal changes 
of pain and discomfort and proposes novel digital pain metrics that may support the 
assessment of pain. Results from this PhD contribute to our understanding of the 
patients’ pain experience and underscores the use of digital pain mapping in 
experimental and clinical research.  
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En klinikers vurdering af en smertetilstand er afhængig af patientens selv-
rapporterede målinger af vedkommendes smerte og ubehag. Desuden vides meget 
lidt om de detaljerede ændringer i smerteintensitet og fordeling mellem 
konsultationer. Momentan vurdering af smerte kan dæmpe erindringsbias og vise sig 
fordelagtig i behandlingen af smerter. Imidlertid er let kvantificerbare mål for 
øjeblikkelig smerte begrænset. Udviklingen af digitale sundhedsteknologier kan 
hjælpe med at overvinde og forbedre disse begrænsninger samt skabe nye 
muligheder for at dykke dybere ned i mekanismerne for smerte. 
Formålet med dette ph.d.-studie var at vurdere spatiotemporale ændringer i 
selvrapporteret smerteintensitet og -fordeling (omfang og udbredelse) i tilstande af 
eksperimentel og klinisk smerte ved hjælp af avancerede digitale 
smertekortlægningsløsninger. Formålet med ph.d.-studiet var (1) at indhøste og 
kvantificere ændringer i intensiteten af momentan smerte og ubehag samt udbredelse 
af smerte over tid og (2) at vurdere fordele, begrænsninger og barrierer i forbindelse 
med brug af smertekortlægningsteknologi. 
Ph.d.-studiet anvendte to forskellige modeller til at fremkalde smerte og ubehag hos 
raske forsøgsdeltagere samt patienter med muskuloskeletale spinale refererede 
smerter. Der blev anvendt en veletableret eksperimentel smertemodel til at 
fremkalde kortvarig akut muskuloskeletal lændesmerte med det formål at vurdere 
dosis-respons-forskelle i den fremkaldte intensitet og udbredelse over tid. En anden 
model påførte eksperimentelt ubehag med det formål at undersøge ændringer i 
perception.  
Det første studie påviste og karakteriserede dosis-respons-forskelle i 
saltvandsinduceret spatiotemporal smerteintensitet og -udbredelse over tid og 
støttede relevansen af gentagen momentan smertemåling. Det andet studie foreslår 
tidligere usete udsving i smerteintensitet og udbredelse over en længerevarende 
periode hos patienter med refererede spinale smerter. Endvidere afslørede 
resultaterne patienternes karakteristika og de barrierer ved brugen, som påvirkede 
overholdelsen af indrapporteringen. Endelig støttede det tredje studie brugen af 
modificerbare animationer til at assistere med kvantificering af realtidsændringer i 
kopslige følelser.  
Afslutningsvis påviser denne ph.d.-afhandling spatiotemporale ændringer i smerte 
og ubehag og afslører nye digitale smertemålesystemer, som kan understøtte 
vurderingen af smerte. Resultaterne bidrager til vores forståelse af patienters 
smerteoplevelse og retfærdiggør brug af digital smertekortlægning i eksperimentelle 
og kliniske forsøg. 
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CHAPTER 1. INTRODUCTION 
1.1 THE ASSESSMENT OF PAIN 
Pain is a multidimensional and subjective sensory perception. The International 
Association of Pain (IASP) defines pain as “an unpleasant sensory and emotional 
experience associated with, or resembling that associated with, actual or potential 
tissue damage, or described in terms of such a damage”1 (1). The subjective nature 
of pain leads patient-reported outcome measures (PROMS), such as intensity ratings 
and quality descriptors, to be the most highly recommended approach during the  
assessment of pain (2). However, it is a clinician’s interpretation of these PROMS 
that can help determine a meaningful picture of the pain experience (3) to assist in 
the clinical decision-making process. Therefore, the accuracy of the patient-clinician 
communication of pain and sensory perceptions plays an essential role in the 
assessment of pain. 
The intensity of pain and sensory perceptions can be rated using different scales, 
such as the Numerical Rating Scale (NRS), the Visual Analogue Scale (VAS), and 
the Verbal Rating Scale (VRS) (4). These intensity rating scales aim to simplify the 
perceived sensation to a number from 0 “no pain” to 10 “worst imaginable pain”. 
Furthermore, these scales rely on the ability of the patients to condense the sensation 
perceived over a past time, to a single number (5).  
Quality descriptors characterize painful sensations (e.g. throbbing, dull ache), as 
well as sensations provoking discomfort, namely dysesthesias (e.g. burning, electric, 
itch) and paraesthesias (e.g. numbness, tingling) (1,7). These quality descriptors 
provide valuable information during assessment (8–10) and play an important role in 
the understanding of mechanisms of pain (2,8,11,12). Questionnaires, such as the 
McGill Pain Questionnaire (MPQ) (13,14) and painDETECT (15,16), are used 
routinely to identify quality descriptors and assist in the differential diagnosis.  
Other common PROMS capture the spatial spread of pain and discomfort using 
body charts. Classic pen-to-paper body charts display 2D silhouettes of a male or 
female body from different viewpoints (anterior, posterior, lateral right, and lateral 
left). Pain drawings can be a useful tool to visually represent the pain distribution 
(extent and location) (17) and improve the understanding of underlying pain 
mechanisms (18–20) in the clinical population. Pain drawings have been used to 
develop maps of pain distribution patterns that have become clinical diagnostic tools 
(21–29), such as dermatome and myotome maps (30), cervical zygapophyseal joint 
pain patterns (31,32), and myofascial trigger point pain patterns (33). However, pain 
maps may have been determined based on cross-sectional studies in healthy 
participants (30,31,33–36). As such, the knowledge obtained from these maps may 
be missing relevant information on how pain and sensory perceptions progress or 
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regress over time (spatiotemporal pattern).  
There are few longitudinal studies outlining changes in the overall regions of pain 
over a sustained period (37–43). Very little is known about the detailed changes in 
pain intensity and distribution over time in experimental and clinical pain and 
whether these changes are relevant to the clinical practice. Therefore, in order to 
advance pain mapping, the development of novel pain metrics would be needed to 
more accurately quantify and capture changes in pain distribution and sensory 
perceptions. At an experimental level, digital pain mapping can explore the dynamic 
relationship between sensory perception and stimulation to gain a deeper 
understanding of pain mechanisms. At a clinical level, digital pain mapping can 
minimize pain recall biases, improve patient-clinician communication, and explore 
changes of pain and discomfort over time, thereby assisting the clinical decision-
making process. 
1.2 THE EVOLUTION OF PAIN MAPPING AND BODY CHARTS  
In 1949, pain drawings were first described as a differential diagnosis tool to assess 
whether pain symptoms originated from organic lesions or functional nervous 
disorders (44). Visual inspection revealed that the pain drawing’s symmetry was a 
key diagnostic feature and concluded that pain drawings depicted a clear visual 
representation of pain syndromes (44). 
Simple visual inspection of pain drawings continued to be used to identify 
differences in pain extent and location. Pain maps that were developed from visual 
inspection are still in use in clinical practice (30–32,44,45). However, the methods 
for the mapping of pain have evolved over time (46). Pain drawings used dots, lines 
and crosses to visually represented the location of different pain and sensory 
perceptions (14,43,47). For example, a cross could represent pain, whereas a 
discontinued line could represent tingling. Other methods divided the body charts 
into different body regions, and patients filled out the area or areas of where their 
pain was located (48–50) and used different colors to report different quality 
descriptors (51). In an effort to advance the quantification of pain extent, grids made 
of small squares were superimposed to a body chart or pain drawings to count the 
number of colored squares (52,53), as an indirect measure of pain extent (pain area). 
Pain drawing scoring systems were then developed as a psychological screening tool 
for low-back pain based on the symmetry, extent, and location of the pain (49,54–
56). However, these scoring systems were not able to be validated or correlated to 
known psychological screening and evaluation tools (57–60). Pain drawings became 
digitized in the 1990s (61–64), and more advanced computerized scoring systems 
were developed using software assessment (65), statistical methods (66), and 
artificial neuronal networks (67,68) to detect patterns of pain distribution. These 
computerized scoring systems have shown similar sensitivity to experienced 
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clinicians to classify pain drawings into different diagnostic categories in patients 
with low-back pain (65–67). The use of pixel-count was also described as a method 
to quantify experimentally evoked paraesthesias (69). However, there is still no gold 
standard to quantify pain extent (70).  
Currently in 2020, patients can indicate the pain distribution (area and location) by 
drawing directly onto a body chart on a mobile device (62,63,71,72). Digital pain 
drawings in 2D or 3D body charts have shown good correlation with pen-to-paper 
pain drawings (61,64,70,73–75). A clear advantage from digital pain drawings is the 
ability to systematically quantify the pain extent by extracting the number of pixels 
from the coloured areas. The use of digital pain drawings to map and track changes 
of pain and discomfort may assist to identify pain patterns (20,76) and reveal 
changes in sensory perceptions (77). A table with a summary of studies using pain 
drawings, including the methodological milestones, has been added at the end of this 
thesis (see appendix). 
1.3 ECOLOGICAL MOMENTARY ASSESSMENT OF SELF-
REPORTED PAIN  
The accuracy of PROMS of pain relies on the patient’s pain memory recall (78–82), 
as a patient’s pain onset may occur a long time before the assessment. Factors 
influencing pain intensity recall include the intensity of the actual experience of pain 
(78,79,83), stress or distress (84,85), and pain catastrophizing (82,86,87). To reduce 
possible pain recall biases (exaggeration or lessening) acquiring electronic PROMS 
(ePROMS) in real-time as they occur (momentary) may offer more accurate 
information (88–90). Additionally, the acquisition of momentary pain ePROMS 
remotely, from the patients’ own environment and context (ecological) can provide 
detailed relevant information (88–90). Ecological momentary assessment (EMA) of 
pain electronic ePROMS can provide momentary pain data repeatedly over time 
between clinical consultations that can be relevant for pain assessment and 
monitoring (88–90). Repeated momentary data collection can assist in characterizing 
and accurately describe the dynamic changes of the experience of pain over an 
extended period (89,90).  
1.4 DIGITAL PAIN MAPPING 
Digital health (eHealth) allows for the acquisition, storage, and sharing of digital 
biomarkers remotely, making eHealth the ideal methodology for the EMA of pain. 
Digital biomarkers are a composite of medical data collected directly by the patient 
(91), from the patient (92), using technology, such as digital platforms, as well as 
applications (apps) and wearables. Pain tracking apps, such as those for pain 
mapping, can acquire digital pain biomarkers, namely intensity ratings, quality 
descriptors, and pain drawings, remotely to reveal the spatiotemporal course of pain 
and discomfort, thereby gaining a broader understanding of the pain experience and 
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improving the accuracy of pain communication.  
1.5 AIMS OF THE PHD THESIS 
This chapter has introduced the interaction among PROMS, EMA, and digital pain 
mapping to acquire digital pain biomarkers. This interaction can lead to the 
identification of changes in pain distribution over prolonged periods. Digital pain 
mapping opens the possibility to capture momentary pain distribution and compare 
the accuracy of pain distribution memory recall. The need for evidence on the 
feasibility of digital pain mapping for the assessment of pain and sensory 
perceptions forms the basis of this PhD. 
The overall aim of this PhD was to explore spatiotemporal changes of pain and 
discomfort using digital pain mapping, as well as exploring digital pain metrics to 
support the assessment of sensory perceptions beyond pain. Three studies were set 
up with specific primary aims: 
1) Quantify changes of pain intensity and distribution over time, in experimentally 
evoked pain as well as in clinical pain, using a digital pain-mapping app. Study I 
determined dose-response spatiotemporal differences in experimental saline-induced 
low-back pain and the pain memory recall. Study II mapped and tracked pain and 
discomfort in patients with non-malignant referred pain from the spine for 12 weeks. 
2) Assess the adjustment behavior of a modifiable animation to capture changes in 
experimentally evoked sensory perceptions. Study III assessed the systematic 
adjustment of two parameters to visually represent changes in experimental tingling 
sensations. 
3) Determine barriers, and limitations of digital pain mapping. Studies II-III 
collected qualitative feedback data from the users to identify barriers, limitations, 
and suggestions for improvement. 
1.6 OVERVIEW 
This thesis is structured to provide a cohesive and logical description of the results 
from the three different studies. Chapter two describes the methods utilized 
throughout this PhD project, whereas chapters three to six present the results, as well 
as the existing literature. Lastly, chapters seven and eight describe the PhD project 
limitations, draw overall conclusions, and discuss future perspectives in digital pain 
mapping. 
Each of the three studies used a different pain mapping technology. Table 1-1 
provides an overview of the three different technologies and pain models used for 
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each of the studies, as well as conceptualizes the studies’ relationship to assess 
changes in pain and discomfort over time.  
Table 1-1. Overview of the three PhD studies outlining the different digital pain 
mapping technologies and pain models utilized. 






induced low-back pain 
Pain intensity ratings and digital 
pain drawings obtained using a 





Pain and discomfort in 
patients with non-
malignant chronic 
spinally referred pain 
Pain intensity ratings and digital 
pain drawings obtained remotely 
using a mobile phone, tablet, or 
computer. 





Prototype of a self-adjustable 
animation to capture changes in 
sensory perceptions. 
 
1.7 PAPERS ASSOCIATED WITH THE DISSERTATION 
The current PhD thesis includes two internationally peer-reviewed papers, and one 
manuscript under peer-review. The first and second paper address the first and third 
goal, whereas the third paper addresses the second and completes the third goal. 
Study I Spatiotemporal patterns of referred pain and recall accuracy: a dose-response 
study. Galve Villa, M., Palsson S., T., Boudreau S.A. Scandinavian Journal of Pain 
(submitted) 
Study II Remote digital pain mapping and tracking in patients with chronic pain. 
Galve Villa, M., Cid Royo A., Bjarkam R, C., Palsson S., T., Boudreau S.A. J Med 
Internet Res (in press). doi:10.2196/21475 
Study III Modifiable motion graphics for capturing sensations. Galve Villa, M., 
Mørch C.D., Palsson T.S., Boudreau S.A. PLos One 2020 Feb 24;15(2): e0229139.
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      





CHAPTER 2. EXPERIMENTAL MODELS 
OF PAIN AND DIGITAL PAIN MAPPING 
TO UNCOVER MECHANISMS OF 
REFERRED PAIN 
Experimental models aim to mimic clinical pain and are used to explore the 
transition from stimulation to perception (psychometrics) to better understand the 
mechanisms of pain (93,94). Experimental models of pain have been used to explore 
patterns of evoked-pain distribution (36,95–98) by activating different nociceptors 
(99). Experimentally evoked muscle pain can induce centrally driven phenomena, 
such as referred pain (93,99,100). Referred pain is perceived at a location distally 
from the stimulation site (94,99).  
 
Hypertonic saline (HS) injections are used to mimic the patterns of local and 
referred pain as seen in clinical conditions (94,100,101), whereas electrical 
stimulations (ES) are used to evoke a range of sensory perceptions (102–104). 
Knowledge about spatiotemporal changes of pain could improve our understanding 
of pain mechanisms dynamic changes. Pain studies may benefit from exploring the 
spatiotemporal changes in pain extent and intensity in healthy and clinical 
populations.  
 
The current thesis focuses on HS and transcutaneous ES. HS intra-muscular 
injections are used in experimental pain research as a transitory acute muscle pain 
model (105), whereas transcutaneous ES are used to explore psychometric 
properties (106–108). Psychometric studies use a variety of stimulations and 
questionnaires to evoke and characterize a range of sensory perceptions. For 
example, differing electrical stimulation intensities can evoke different perceptions 
ranging from tingling to hammering (109). Changes in the intensity of the sensory 
perceptions are assessed using VAS or NRS. However, there are no specific 
PROMS to quantify changes in sensory perception.  
2.1 EXPERIMENTAL MODELS OF PAIN AND OTHER 
SENSATIONS  
2.1.1 EXPERIMENTAL MODEL OF LOW-BACK PAIN 
Study I used two different doses of HS (5.8%) injections, as a model of non-specific 
acute referred low-back pain, to determine spatiotemporal dose-response differences 
in healthy participants. A single low-dose (0.5ml) or a high-dose (1.0ml) HS bolus 
was injected into the belly of the right gluteus medium muscle aiming to mimic soft-
tissue acute low-back pain.  
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2.1.2 EXPERIMENTAL MODEL OF TINGLING  
Study III used a range of transcutaneous ES to elicit sensory perceptions to the 
glabrous aspect of the index fingertip of the left hand. The protocol for electrically 
evoked tingling sensations consisted of 8 randomized ES intensities (2, 3, 3.5, 4, 4.5, 
5, 5.5 and 6mA) with a constant number of bursts, frequency, duration of the burst 
and pulse width (1 burst, 250Hz, 4 seconds and 50μs, respectively), repeated three 
times. The ES were applied using surface electrodes (Neuroline 700, Ambu A/S, 
Denmark) placed on the proximal and distal phalanges and connected to an isolated 
bipolar constant current stimulator (DS5, Digitimer Ltd, Hertfordshire, UK). The 
delivery of the stimulations was controlled by custom-made software (Mr. Kick III    
v. 3.0, Aalborg University).  
2.2 THE INTENSITY OF PAIN AND SENSORY PERCEPTIONS 
The NRS and the VAS are well-established, validated methods to obtain a single 
number representing the intensity of the perceived pain experience (110,111). A 
modern take on the classic VAS is the electronic Color Analogue Scale (eCAS). The 
eCAS is a coloured line (green, yellow, red) accompanied by the words “no pain”, 
“moderate pain”, and “severe pain”, representing a continuum between “no pain” on 
the left end of the scale and “worst imaginable pain” on the right end of the scale 
(112,113). Electronic visual analogues scales (eVAS) for the assessment of pain 
have been validated in electronic format (114–116). An eNRS (study I), an eCAS 
(study II), and a classic NRS (study III) were used to acquire momentary intensity 
ratings (current), as well as the average intensity for the last 24 hours (usual). The 
different scales were appropriate for each of the study designs and were not intended 
for comparison between them. 
2.3 DIGITAL PAIN MAPPING TO QUANTIFY AND QUALIFY THE 
PAIN EXPERIENCE  
Digital pain mapping can help in the assessment of pain remotely, over a sustained 
period. Digital pain drawings can be assessed using image processing techniques 
(72) to determine novel pain distribution metrics (95,117). For example, digital pain 
drawings can be superimposed to create overlay images (76) for visualizing of 
changes in pain distribution over time (study I, see section 3.1), and identify 
common patterns or locations of pain (76). Additionally, digital pain mapping 
allows comparisons of the similarities in pain extent and distribution, between two 
digital pain drawings. 
Digital pain mapping enables detailed patient-clinician communication, and may 
improve the clinician’s understanding of the patient’s pain (19). Two digital pain-
mapping apps, the Navigate Pain android and web app version, were used to acquire 
pain intensity ratings as well as pain and discomfort extent. The pain and discomfort 
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extent can be quantified by extracting the number of pixels (61,72,74). This pixel 
count includes both, localized and referred pain and discomfort. A third digital pain-
mapping app, Animate Pain, used self-adjustable animations to quantify changes in 
visual representations of sensory perceptions. 
2.3.1 DIGITAL PAIN MAPPING APPLICATIONS 
Study I used the Navigate Pain app version 0.1.9.9.3 for android (Aalborg 
University, Denmark) to capture changes in experimental saline-induced low-back 
pain using touch-screen technology (Fig. 2-1). A digital tablet (Samsung Galaxy 
Note 10.1 2014 Edition) displayed a high-resolution 2D male body chart in a 
posterior view. Participants used a stylus digital pen (S-pen) to draw the location and 
area of the pain on the body chart every 30 seconds until pain cessation (NRS=0). 
This digital drawing time-lapse captures the spatiotemporal patterns of momentary 
pain intensity and extent over time.  
 
Fig. 2-1: Digital pain-mapping application to quantify the pain extent (study I). Navigate 
Pain version 0.1.9.9.3 (Aalborg University, Denmark) displaying the selection of 2D body 
charts and the anterior view of a detailed male body chart. 
Study II used a new web-based pain-mapping app, Navigate Pain, version 2 
(Aglance Solutions, Denmark) (Fig. 2-2), equipped with extra functions to enable 
remote and weekly digital pain reports. Each pain report consisted of pain drawings 
and pain intensity (usual and current) ratings. A computer mouse, or touch-screen 
technology, was used to draw the location and area of pain onto a female, or a male 
pseudo-3D body avatar from different viewpoints (anterior, posterior, lateral right 
and lateral left). Ten different color-coded discomfort quality descriptors were 
available to be selected (tingling, throbbing, stabbing, dull aching, numbness, itchy, 
electric, cold, burning, and other), as well as the general descriptor “pain”. 
Navigate Pain APP Navigate PainTM platform
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Additionally, a small free-text section was available for patients to comment about 
the pain experience. 
 
Fig. 2-2: Sequence of screenshots from the web-based digital pain-mapping application to 
quantify and qualify the pain experience (study II). Navigate Pain (Aglance Solutions, 
Denmark) displaying the different steps required to complete a pain report. (A) Selection of 
the color-coded quality descriptor followed by (B) the intensity of the descriptors. (C) 
Completion of the digital pain drawing from different viewpoints (only anterior view 
displayed for illustration purposes). Steps A-C may be repeated as often as required with the 
different quality descriptors. (D) At the end of each pain report, patients rated their usual 
(average) and current pain intensity on an electronic color analogue scale. Reproduced with 
permission (Aglance Solutions ApS). 
2.3.2 METRICS TO QUANTIFY PAIN DISTRIBUTION.  
Similarity between two pain drawings: Jaccard index 
The similarity between two pain drawings can be calculated and expressed using a 
Jaccard similarity coefficient or Jaccard index (76). A higher Jaccard index 
represents a greater pixel overlap between two pain drawings and indirectly 
quantifies the pain distribution similarity (18,19,76). For example, the Jaccard index 
can be a useful tool to assess the accuracy of the experimental pain distribution 
recall (chapter 4). Furthermore, to assess temporal changes in pain distribution, three 
novel pain distribution metrics were evaluated. These pain distribution metrics can 
uncover changes in the pain spread, morphology (shape), and location to reveal 








Distance from origin: Vector length 
The vector length measures the expansion or spread of the pain, and it is defined as 
the maximum distance from the injection site to the farthest-located pixel on the 
pain drawing. The vector length is measured in pixels and considers all the pain 
areas within the pain drawing.  
Shape morphology: Bounding box area 
Drawings of pain may differ in morphology and are, arguably, more likely to be 
irregularly shaped rather than perfectly circular or square. The description of 
irregular shapes and quantification can, therefore, be complex. A bounding box area 
is calculated by determining the length and width of a box that fully enclose the area 
of pain. The bounding box area also encloses discontinuous pain, in cases where 
there is more than one area of pain. The resulting length and width vectors simplify 
the information about the shape of the pain area or areas, enabling an easier 
interpretation in statistical outcomes about generalized differences or changes in 
pain area morphology.  
Shifts in general location: Centroid 
Shifts in the location of pain, for example during recall of pain, may occur. 
Additionally, due to the possibility of irregular morphologies in the area of reported 
pain, assessing changes in the location can be difficult. Therefore, calculating the 
centroid of the pain area can determine more detailed information about the location 
of the pain area whilst accounting for changes in pain area morphology. The 
centroid is the central point (geometric centre) of the area of pain. The centroid is 
determined by a X- coordinate and a Y-coordinate. These coordinates determine the 
centroid location horizontally and vertically, respectively.  
2.3.3 VISUAL REPRESENTATIONS OF SENSORY 
PERCEPTIONS 
Study III used state-of-the-art software to quantify changes to sensory perceptions. 
Animate Pain version 1.0 (Aalborg University, Denmark) displayed a modifiable 
animation on an interactive dashboard (Fig. 2-3). The dashboard displayed a high-
resolution image (canvas) of the glabrous aspect of the left hand. An animation 
designed to represent the sensation of tingling (dots appearing and disappearing) 
appeared when drawing on the canvas with the computer mouse. Adjustments of 
two digital visual analogue scales (dVAS), located on the dashboard, modified the 
animation’s parameters, to visually modify the density and speed of the dots from 
the animation in real-time.  
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Fig. 2-3: Digital pain mapping to quantify changes in sensory perceptions. (A) Animate 
Pain (Aalborg University, Denmark) dashboard displaying the digital body chart 
representing the glabrous aspect of the left hand. The digital Visual Analogue Scales (dVAS) 
modify the density and speed parameters. Images are enlarged to take a snapshot of the 
animation, as well as the density and speed dVAS. (B) Enlarged images of the animation, for 
illustration purposes, show a range of different density values from 0 (minimum), 0.2, 0.5 to 1 
(maximal). Reproduced with permission (Galve Villa et al., 2020). 
2.4 QUESTIONNAIRES FOR THE ASSESSMENT OF THE PAIN 
EXPERIENCE 
Pain catastrophizing (82,86,87) and stress (84,85) are known psychological factors 
that can influence, negatively or positively, the recall of pain intensity. To assess the 
influence of psychological factors during experimental pain, the Pain 
Catastrophizing Scale (PCS) and the Perceived Stress Scale (PSS) were assessed at 
baseline (Study I). The PCS has been used to evaluate pain-related catastrophizing 
thoughts as a negative anticipatory response associated with higher pain intensity 
(118,119). High pain catastrophizing ratings are known to positively influence the 
pain intensity recall (82,86,87). The PSS measures the degree of perceived stress 
levels by rating feelings and thoughts that may have been experienced during the 
previous month (120). Stress in known to influence the quantity and quality of 
memory formation (121–126).  
Study II to assess whether catastrophizing and disability influenced intensity and 
extent in clinical pain. Disability was measured using the Oswestry Disability Index 
(ODI) and the Neck Disability Index (NDI) for patients with pain referred from the 
low-back and the cervical spine, respectively. The relationships among pain 
intensity, extent, disability (ODI/NDI) and catastrophizing scores are unclear. Some 




CHAPTER 3. DIGITAL PAIN REPORTS 
REVEAL SPATIOTEMPORAL 
CHANGES IN REFERRED PAIN 
Studies have shown that pain drawings completed by the patients themselves are 
more reliable than pain drawings completed by clinicians using the information 
obtained during anamnesis (137). Therefore, better patient-clinician communication 
of pain PROMS is an essential part of pain assessment. EMA of pain can be used to 
improve pain communication, minimize pain recall bias (see section 1.3), and 
optimize the clinical decision-making process.  
Traditionally, pain intensity is assessed by either the average or the most intense 
(peak) pain intensity, and pain distribution is assessed by the largest area of referred 
pain (extent). Studies assessing the course of pain in patients with musculoskeletal 
chronic spinal pain have identified some patients may develop either stable or 
fluctuating temporal patterns of pain intensity (17,37,39,41,138,139). Furthermore, 
patients can show stable (localized or widespread) or variable spatiotemporal 
patterns of pain extent (42,140). However, these studies utilized paper-based surveys 
sent at intermittent time points over a prolonged period, and may, therefore, have 
missed the dynamic changes that could have occurred on a daily or weekly time 
scale.  
In the research setting, knowledge of spatiotemporal changes evoked by different 
experimental models of pain may deepen the understanding of the mechanisms of 
referred pain. For example, in mustard oil evoked pain, dose-response differences 
have been identified, with a high dose evoking more intense peak pain than a low 
dose (96). However, dose-response differences in peak pain intensity have not been 
identified in the capsaicin pain model (97). It is unknown whether higher doses of 
experimentally evoked pain using different models are associated with more severe 
evoked pain (intensity and extent). It is also unknown whether temporal changes in 
evoked pain intensity are associated with changes in the evoked referred pain extent. 
Studies I-II were set up to quantify spatiotemporal changes in momentary pain, as 
evoked in healthy participants (Study I), and in a clinical population (Study II). 
Study I quantified dose-response differences and recall ability in pain intensity, 
extent, and distribution using an experimental model of non-specific acute low-back 
referred pain. Study II used digital pain mapping to acquire weekly pain ePROMS 
remotely, in patients with chronic spinally referred pain.  
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3.1 DOSE-RESPONSE DIFFERENCES IN EXPERIMENTAL PAIN 
(STUDY I) 
To assess dose-response differences, participants from study I received either a low-
dose (0.5ml) or a high-dose (1.0ml) injection of HS and rated the pain intensity 
every 30 seconds until pain cessation. Participants were additionally randomized 
into drawing or non-drawing groups, resulting in a total of four groups: low-dose 
drawing (N=13), low-dose non-drawing (N=15), high-dose drawing (N=14), and 
high-dose non-drawing (N=15). Participants from both drawing groups captured the 
pain distribution, as well as the pain intensity every 30 seconds (see sections 2.1.1 
and 2.3.1).  
There were no differences in pain intensity and extent over time between the low-
dose drawing and low-dose non-drawing groups (p<0.05), as well as the high-dose 
drawing and high-dose non-drawing groups (p<0.05). Digital momentary assessment 
of pain revealed dose-response differences in HS-evoked pain as assessed over time, 
comparing the area under the pain intensity-time curve (z=-1.67, p<0.01), as well as 
the for area under the pain extent-time curve (z=-2.56, p<0.01). (Fig. 3-1). However, 
dose-response differences were not identified at peak pain for intensity and extent. 
Additionally, study I showed that peak pain intensity was strongly associated with 
the evoked peak pain extent only when induced from a low dose (rs=0.77, 35%, 
p<0.01), but not from a high dose. When combining data from the low and the high 
doses (pooled data) the peak pain intensity was not associated with the pain extent.  
Study I showed that pain catastrophizing can be a factor influencing experimentally 
evoked pain intensity in heathy participants, concurring with previous studies (87). 
However, study I determined that pain extent may not be directly influenced by pain 
catastrophizing. Therefore, pain extent may be a relevant measure, in addition to 
pain intensity, during the pain assessment. This lack of association between pain 
extent and pain catastrophizing may not be applicable to the clinical population 
where catastrophizing scores may be higher, and the pain experience may also be 
more intense and prolonged.  
Lei and colleagues showed a dose-response difference in HS-evoked pain over time 
and at peak pain (141,142). Study I showed dose response differences only over 
time. These contradicting results may be explained by the different HS doses and 
administration methods between the studies. Lei used much larger doses of HS 
(2.0ml and 4.8ml) administered by infusion (141,142), whereas study I (0.5ml and 
1ml) administered by bolus injection. In Lei’s study, the 2.0ml and 4.8ml HS-doses 
evoked a mean peak pain intensity (VAS) of 4.5 and 8 out of 10 (141). Study I 
evoked a mean peak pain intensity of 4 out of 10 for the low-dose (0.5ml), and 5 out 
of 10 for the and high-dose (1.0ml). The lower doses from each study differed by 
fourfold (0.5ml and 2.0ml) and evoked similar peak pain intensity. However, the 
pain duration was considerably longer (by approximately 6 minutes) for the higher 
 
31 
dose. On the other hand, the high dose from Lei’s study evoked a considerably more 
intense pain intensity and pain duration (by approximately 15 minutes) than the high 
dose from study I. Therefore, future experimental studies could use lower doses of 
HS to determine dose-response differences over time, whereas higher doses could be 
necessary to assess dose-response differences at peak pain. 
 
Fig. 3-1: Dose-response differences over time in pain intensity and extent immediately 
following (time=0) an injection of hypertonic saline (5.8%) into the right gluteus medius 
muscle. A) Pain intensity ratings from for the low-dose (0.5ml) (N=27) and the high-dose 
(1.0ml) (N=27) drawing and non-drawing groups. B) Evoked pain area as measured in pixels 
for the low-dose drawing (N=13) and the high-dose-drawing (N=13) groups. A higher dose of 
HS evoked a longer pain duration (#) and greater area under the pain intensity-time and pain 
extent-time curves (*) than for the low-dose (p<0.01). Data are expressed as mean and 
standard error of the mean (SEM). 
Novel findings of dose-response spatiotemporal differences were shown as 
measured by pain distribution metrics (see section 2.3.1). These metrics showed a 
greater overall spread in pain, as reflected by the size of the bounding box area, and 
a larger spread laterally towards the hip (X coordinate centroid) over time for the 
1.0ml than for the 0.5ml dose. However, the distance from the injection site (vector 
length) was similar between doses. Therefore, HS evokes a larger spread 
(morphology shape) in pain by increasing the dose. These pain distribution metrics 
were not able to identify intra-dose spatiotemporal patterns of pain distribution for 
the 0.5ml, or the 1.0 ml dose. The lack of clear patterns of pain distribution for each 
of the HS doses may be explained by a large variability in pain extent and the 
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identify spatiotemporal patterns of pain distribution may need to use a high dose of 
HS to evoke more intense and extensive pain. 
3.2 FLUCTUATIONS IN CLINICAL PAIN INTENSITY AND EXTENT 
(STUDY II) 
Patients with chronic pain (N=78) were requested to submit weekly digital pain 
reports to map, track, and quantify changes of pain intensity and distribution over 3-
months (143). Sixty-five patients submitted, at least, one pain report over a 12-week 
period. Digital mapping and tracking of patients with non-malignant (somatic and 
neuropathic) chronic spinally referred pain provided detailed information about the 
changes in intensity (usual and current) and extent of pain and discomfort over time 
(see sections 2.2 and 2.3). Fluctuations in the pain intensity (usual χ2(11) = 145.34, p 
< 0.001; current χ2(11) = 105.66, p < 0.001), and pain and discomfort extent (χ2(11) 
= 48.74, p < 0.001), over 12 weeks were revealed (Fig. 3-2).  
Data obtained from the weekly digital pain reports were pooled to assess whether 
the weekly fluctuations were also identified on a monthly interval. Results showed 
similar pain extent and intensity ratings when assessed monthly (p>0.05). These 
results suggest that frequent assessment can capture fluctuations of pain, supporting 
the use of digital pain mapping for the acquisition of digital pain biomarkers. 
 
Fig. 3-2. Fluctuations in pain and discomfort extent and intensity, over a 12-week period, 
in patients with non-malignant chronic spinally referred pain (N=65). Graphs showing 
fluctuations of pain area (A), usual (B) and current (C) pain intensity ratings over the 12-
week period. The box and whiskers graphic show the median of the overall pain area and 
intensity in the different weeks. The whiskers are drawn down to the 10th percentile and up to 
the 90th. Points below and above the whiskers are drawn as individual dots. Reproduced with 
permission (Galve Villa et al. 2020). 
Observation of the individual pain drawings highlighted that patients reporting a 
larger pain extent pain showed a greater pain extent variability, as opposed to 
patients reporting a lesser pain extent that tended to remain stable over time (rs=0.25 
(3%), p<0.001) (Fig. 3-3).  





























































































Fig. 3-3. The larger the mean pain extent, the more likely it is that the pain extent will vary 
over time. The graphical relationship between the mean and standard deviation for the 
overall pain extent could explain the group pain fluctuations in patients with non-malignant 
chronic spinally referred pain. 
3.2.1 THE INFLUENCE OF PAIN CATASTROPHIZING 
AND DISABILITY ON CLINICAL PAIN 
At baseline, patients from study II were asked to choose their primary pain site 
(cervical spine or low-back pain) to explore differences in the quality descriptors 
selection, as well as disability and pain catastrophizing scores (see section 2.4). A 
multiple linear regression determined that current pain intensity ratings, disability, 
and pain catastrophizing scores predicted the pain extent in patients with low-back 
pain as their primary pain site (F(3,33)=5.28, p<0.05, R2=32%). Only the pain 
intensity added statistical significance to the prediction (p>0.05). However, these 
same variables did not predict the pain extent in patients with cervical pain as their 
primary site. 
A weak correlation between pain intensity (usual and current) and extent was found 
(rs=0.23 and 0.25, respectively, R2=3%, P<.001), suggesting that patients with a 
larger pain extent may also have more intense pain, but it does not explain the 
intensity variance. These results are similar to previous studies (127,144–146), 
suggesting that the assessment of changes in pain extent may be as relevant as the 
assessment of changes in pain intensity for the management of pain. This means, in 
neurophysiology terms, that more intense pain may have activated the latent 
collateral synaptic connections from the dorsal horn, increasing the extent of afferent 
information (147). This larger afferent information may be perceived as a larger area 
of pain extent (referred pain). 
 
Patients from study II did not report pain catastrophizing scores high enough to be 
considered “catastrophizer thinkers” (scores above 30 out of 52), but they did report 
high levels of disability. This was an unexpected finding as higher pain 
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catastrophizing scores are generally associated with a higher level of disability 
(118,148–150). However, it remains unclear how disability and catastrophizing 
scores influence pain intensity and pain extent. Our study could not show any 
associations between baseline pain catastrophizing and disability scores with pain 
intensity and extent (p>0.5), in line with previous findings in similar populations 
(55,58,127). However, positive associations for total extent and disability scores 
(18,129–133), as well as pain catastrophizing (128,129,134–136) have been shown 
in patients with chronic musculoskeletal pain. Study II assessed pain catastrophizing 
and disability only at baseline. Therefore, it is possible that variations of 
catastrophizing and disability scores over time could be associated with variations of 
pain intensity and extent. 
3.3 CONSISTENCY OF PAIN AND DISCOMFORT QUALITY 
DESCRIPTORS (STUDY II) 
The weekly digital pain reports included quality descriptors, as selected from a list 
of eleven possible words (see section 2.3.1). Contrary to the weekly fluctuations 
seen in pain intensity and extent, the selection of pain quality descriptors remained 
stable over time as a group (p>0.05) (Fig. 3-4).  
Fig. 3-4: Consistency of pain and discomfort quality descriptor selection spanning 12 weeks 
in patients with non-malignant chronic spinally referred pain. A quality descriptor was 
accounted for only once a week, for each of the patients, independently of the submitted 
number of pain reports with that same quality. “Pain” and “dull aching” were the most 
frequently selected descriptors, followed by “numbness”, “burning”, and “stabbing”. 
“Itchy”, “cold”, and the general descriptor “other” were the least selected. Reproduced with 
permission (Galve Villa et al., 2020). 
Pain and dull aching were selected by 55-76% of the patients and was similar based 
on gender and primary pain site. Interestingly, the males from the cervical pain 
cohort did not use the quality descriptors cold, itchy, or other. Gender differences 
have been identified in pain perception for chronic pain conditions, but generally 
focused on pain intensity and severity (151–156), with few studies exploring gender 




































differences in quality descriptors. Similarly to our study, Jensen et al (151) found no 
gender differences among different chronic pain conditions, including back pain and 
fibromyalgia. However, gender differences in the selection of quality descriptors for 
shoulder pain have been found using a list with 36 Chinese quality descriptors (155). 
This lack of differences in gender  and primary pain site, supports the notion that the 
pain experience is driven by underlying mechanisms (157–160), rather than pain 
location or diagnosis.  
3.4 DIGITAL PAIN MAPPING TO CAPTURE THE CONTEXT OF 
PAIN 
Upon submitting a pain mapping report, a comment section was available for 
patients to add additional information not captured by the pain reports but still 
important for the patient (161). Eight patients (10%) voluntarily submitted 225 free-
text comments with the pain reports. Six female patients with low-back pain 
submitted 83% (N=187) of these comments, whereas two male patients with neck 
pain wrote the remaining 17% (N=36) of comments. Although the comments were 
voluntary, a review showed that patients utilized this section to rationalize their pain 
reports. These comments were categorized into two themes: justification and further 
description. Justification of the pain experienced included physical and 
psychological factors that appeared to increase or improve the pain. Description of 
the pain experienced included other symptoms and explanations not captured within 
the pain drawings (Table 3-2).  
Qualitative data obtained from the pain report comments gave some context to the 
weekly pain fluctuations. The results suggest that (i) some patients are aware of 
activities or life events that influence their pain, such as social gatherings or 
physically demanding activities, (ii) that the full impact of pain was not fully 
captured by the pain reports, and (iii) that perhaps more quality descriptors were 
necessary. Knowledge and awareness of the activities that influence pain could lead 
to better understanding of the pain condition, as well as to optimize pain 
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Table 3-2. Selection of comments extracted from the patients’ pain reports divided into 
themes.  
Justification of the pain experienced Description of the pain experienced 
-Amitriptyline increased to 10mg in the   
evening. 
-Alternated between severe tenderness and 
pain. 
-On holidays, poor bed. -Feeling tired all day. 
-Weather unstable. Cool and humid. -Feeling very tired and inflamed. 
-Daughter had celebrations yesterday. -Cramps from the knees and upwards. 
-Packing for holidays. Stressed out. -I don’t feel my legs sometimes. 
-Walked a lot. 14 km in 2 days. -Diffuse tenderness. 
-Relaxing completely. Inactive! -Provoked by the extension of the leg. 
-Beautiful weather. Relaxed all day. -Acute, intense pain when lying down. 
-Attended psychologist. It helped. -Feels mostly stiff. 
-Vacuumed and watered the garden. -Worst on the left side, down the leg. 
-Painted using a ladder for the last 3 days. -Constant tenderness. 
- Back at work after holidays. It feels worse. -Pressure, numbness, deep tenderness. 
- My back feels very tired. I had guests 
yesterday. 
-Radiating towards the left hand. Headache 4 
times. 




3.5 SUMMARY OF THE MAIN FINDINGS FROM STUDIES I-II 
(MOMENTARY PAIN ASSESSMENT) 
Studies I and II used a pain-mapping app to track experimental and clinical pain, 
respectively, over a prolonged period. The findings from studies I and II revealed 
that: 
• The dose-response spatiotemporal differences in HS evoked-pain are consistent 
with the limited literature available. However, dose-response similarities found at 
peak pain contradict previous findings.  
• There is no association between experimental peak pain intensity and extent in HS 
evoked pain.  
• Novel pain distribution metrics (i.e. bounding box area, centroid, vector length) 
were identified as a useful tool to determine spatiotemporal patterns of experimental 
pain.  
• In patients with non-malignant chronic spinally referred pain, fluctuations in 
weekly pain intensity and extent were evident, as captured remotely. However, the 
selection of pain and discomfort quality descriptors remained consistent over time.  
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• In patients with non-malignant chronic spinally referred pain, there is a weak 
association between pain intensity ratings and pain extent.  
• Digital pain-mapping apps can be a useful communication tool to acquire detailed 
pain reports remotely, repeatedly over time. However, awareness of the patients’ 
context affecting the fluctuations in pain intensity and extent may be key in clinical 
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CHAPTER 4. ASSESSING THE RECALL 
ACCURACY OF PAIN REPORTS USING 
DIGITAL PAIN MAPPING 
Pain extent and distribution have been used to guide the differential diagnosis of 
somatic referred low-back pain and radicular low-back pain (162–164). Patterns of 
pain above or below the knee can suggest somatic or radicular pain, respectively, 
leading towards different pain management.  
Clinician’s depend on recalled pain PROMS as, likely, there is a time delay from the 
pain onset until the clinical assessment. Pain intensity recall can be affected by 
psychological (e.g. pain catastrophizing thoughts, perceived stress), social, and 
cultural factors in the clinical population (128,165–169). Additionally, pain 
catastrophizing is also a factor known to influence the recall of pain intensity in 
experimental pain (87). The relevance of the momentary assessment of pain extent, 
determined in the current PhD thesis, raises questions concerning the accuracy of the 
pain extent recall. 
There are no studies currently exploring the recall accuracy of pain extent and 
distribution, as well as factors that may influence the recall accuracy. Furthermore, it 
is unknown whether the reporting of momentary pain (by way of digital pain 
drawings) influences the accuracy of the pain extent and distribution recall at a later 
time. Therefore, a goal of study I was to assess the influence of momentary pain 
reporting on the accuracy of pain recalled 7-days later. To our knowledge, study I 
explores for the first time the recall accuracy of pain distribution and extent using 
digital pain mapping seven days after inducing experimental low-back pain.  
4.1 THE ACCURACY OF PAIN INTENSITY AND DISTRIBUTION 
RECALL (STUDY I) 
Participants (N=57) were randomized at baseline into either a low-dose drawing 
(N=13), low-dose non-drawing (N=15), high-dose drawing (N=14), or high-dose 
non-drawing (N=15) group (see section 3.1). Seven days later, all the participants 
were invited to recall the peak pain intensity and complete a pain drawing 
representing the largest pain distribution evoked by the injection at baseline. 
Intensity ratings and pain drawings between the baseline and recall sessions were 
compared to assess recall accuracy among the four groups. 
The pain intensity accuracy was assessed by calculating the intensity recall error. 
The accuracy of the pain distribution recall was assessed by calculating the extent 
(pixels) of the recall error, the Jaccard index, the homogeneity of variance, and 
comparing the pain distribution metrics. Results showed no differences in intensity, 
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extent, and distribution. Additionally, results showed a low recall error for intensity 
and extent, indicating a good recall accuracy in intensity, extent, and distribution 
among the four groups. Therefore, the continuous drawing task did not influence the 
accuracy of the pain distribution recall. Similar pain intensity recall accuracy results 
have been shown in cold-pressure test evoked-pain (87). These results suggest that a 
seven-day period does not affect the pain memory recall accuracy in healthy 
participants following a single pain event. 
4.2 FACTORS THAT MAY INFLUENCE MOMENTARY AND 
RECALL EXPERIMENTAL PAIN 
Even though there was a similar peak pain intensity and extent between two 
different doses of HS, study I showed that peak pain intensity was strongly 
associated with the evoked peak pain extent following a low dose of HS, but not a 
high dose (see section 3.1). These dose-response differences suggest that (i) the 
experimentally evoked pain intensity may not be associated with the extent of 
referred pain following HS injections, or (ii) the high dose may have reached a 
ceiling-effect in the evoked extent.  
Pooled data revealed that momentary peak pain intensity was the only factor that 
may have influenced the pain extent recall (rs=0.60, R2=43%, p<0.01), similar to the 
association found between intensity and extent in clinical pain (study II). 
Additionally, pain catastrophizing was asserted as a factor associated with the 
perception of momentary peak pain (rs=0.54, R2=14%, p<0.01), and recalled peak 
pain intensity (rs=0.46, R2=22%, p<0.01), in experimentally evoked pain, as shown 
in other studies (87,170). Furthermore, pain catastrophizing is associated with 
perceived stress ratings (rs=0.36, R2=14%, p<0.01), in healthy participants. 
4.3 SUMMARY OF THE MAIN FINDINGS FROM STUDY I (PAIN 
RECALL ACCURACY) 
Study I assessed the influence of a continuous pain drawing task on the accuracy of 
the pain distribution memory recall. The findings from study I revealed that: 
• Participants had a good pain intensity, extent, and distribution recall accuracy in 
response to a non-specific acute soft tissue low-back pain model seven days later. 
Continuous pain drawings did not influence the pain memory recall.  
• Pain catastrophizing is re-affirmed as a psychological factor influencing 
momentary and recall intensity in experimental pain.  
• Experimentally evoked peak pain extent is associated with peak pain intensity but 
not with pain catastrophizing. Therefore, pain extent may be less susceptible to 
factors influencing pain PROMS in healthy participants. 
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CHAPTER 5. IN-DEPTH ANALYSIS OF 
THE CLINICAL USE OF DIGITAL PAIN 
MAPPING 
The feasibility of using digital pain mapping for tracking momentary clinical pain 
intensity and distribution remotely, relies on the patients’ usability, ease of use 
(171,172), and reporting compliance (173). To facilitate the digital pain-mapping 
compliance the app needs to be easy to use (174) to create a seamless transition from 
pain and discomfort perception to communication via a digital report. Additionally, 
users (patients and clinicians) need to feel that submitting pain reports adds value by 
enhancing their communications experience (175,176), thus is beneficial and 
meaningful for them. Meaningfulness may be the key to understand the users, 
motivation to adopt the technology and, subsequently, achieve a successful 
implementation in healthcare settings (177). Study II revealed good usability and 
acceptance scores, as rated using a System Usability Scale (SUS) and a modified 
Technology Acceptance Model (mTAM) electronic questionnaires. However, 
reporting compliance ratings exposed differences between users’ characteristics. 
Therefore, exploring the barriers of use that lead to low compliance rates may be 
relevant to maximize the advantages that digital pain mapping can bring to the 
clinical assessment of pain. 
In chapter 3, we reviewed how digital pain mapping can reveal spatiotemporal 
changes in pain that would otherwise go unseen. These changes can provide timely, 
detailed information to support clinical decision-making. Furthermore, digital pain 
mapping allows for further development of pain mapping metrics and exploration of 
the value for assessing and treating clinical pain. 
5.1 DIGITAL PAIN-MAPPING REPORTING COMPLIANCE.  
(STUDY II) 
Patients (N= 78) were asked to complete one pain report weekly during a 12-week 
period. Patients were aware that the pain drawings were not going to be reviewed by 
a clinician. However, they were offered a summary of their pain reports at any time 
during the study. Once a patient registered with the pain-mapping app, a weekly 
reminder e-mail was set up. At the 6-week mid-point, patients were retrospectively 
divided into those who had submitted the pain reports weekly (regular users, N=35) 
and those who submitted pain reports less frequently (non-regular users, N=27).  
The total number of submitted pain reports was 3,863. A total of 65 patients 
(compliance rate at study start=83%) submitted a total of 518 pain reports during the 
first week. A drop-out rate of 32% (N=21) of patients by the end of the study 
resulted in a retention rate (number of participants) of 56% at the 12-week point (fig. 
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
42 
5-1), determining an average patient retention rate of 56%. The number of pain 
reports submitted (reporting compliance) was reduced from 518 pain reports during 
the first week to 212 at 12 weeks, representing a compliance rate reduction of 60%. 
The largest drop in the compliance rate occurred during the second week, where the 
retention rate decreased by 22% (N=14). It is possible that this initially large drop in 
retention and, subsequently, compliance was due to a loss of enthusiasm and lack of 
perceived benefit. The retention and compliance rates steadily decreased during the 
first 6 weeks, where the retention rate dropped by 25%, from 65 to 49 patients, and 
the compliance rate dropped by 52%, from 518 to 251 pain drawings. Only one 
patient requested a summary, suggesting that compliance did not hinge on this offer. 
Studies using EMA to track pain intensity in clinical settings (88,90,178) reported a 
compliance rate of 85%, similar to our 83% compliance rate at week-1. 
Additionally, a meta-analysis of EMA studies (88) identified an average compliance 
rate decline of 2% per week of data collection. A hypothetical 2% weekly decline 
from the 83% compliance rate at week-1, would result in a week-12 compliance rate 
of 61%, similar to the actual end-of-study rate of 59%. Therefore, we can conclude 
the retention and the compliance rates from this study may not have differed if the 
pain reports would have been used clinically. 
 
Fig. 5-1. Number of active participants and submitted pain reports during the 12-week 
study period. There was an immediate drop in the number of patients (retention) using the 
digital pain-mapping app following the initial recruitment (left). Subsequently, the retention 
stabilized until the end of the study. There was a small reduction in retention during some 
specific weeks, which may coincide with the participants’ peak holiday period. Similarly, 
there was a gradual reduction in the number of submitted pain reports (reporting 
compliance) for the first six weeks of the study (mid-point), and it subsequently reached 
plateau for the remainder of the study (right).  
A range of working strategies to improve or maintain patient motivation and 
engagement during EMA of pain studies include the use of monetary incentives, 
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participant-researcher direct interaction, limiting the duration of the data collection 
period, and the creation of a “rapid-feedback” in relation to the individual data 
collection (88). “Rapid feedback” in digital pain mapping could be a simple 
comparison between the current and a past pain report for a quick visualization on 
the pain progress.  
In view of the steady decline in reporting compliance at week-6, a participant-
researcher direct interaction strategy was developed, where each patient received a 
hand-written thank you card. The aim of the card was to thank the patients for 
participating in the study, acknowledging their time and effort during the 12-weeks, 
and the importance of their contribution to the study success. Subsequently, the 
reporting compliance rate remained stable until the end of the study. The 
motivational effect from the card may be considered as positive reinforcement 
conditioning. Positive reinforcement rewards behavior considered good, to 
encourage the good behavior to continue. In this case, the good behavior was 
submitting weekly pain reports and the reward was thanking the participants and 
showing our appreciation with compliments and positive statements in an 
individualized manner. Although it cannot be concluded that the thank you card had 
an effect in the stable compliance rate for the remaining of the study, the consistent 
retention rate should be considered as an additional strategy to maintain reporting 
compliance. 
5.1.1 FACTORS INFLUENCING REPORTING 
COMPLIANCE  
To identify factors influencing compliance using digital pain mapping, differences 
in recruitment strategies, age, gender, as well as pain intensity and extent were 
examined. In study II, patients were recruited by collaborating clinicians from a 
hospital or through social media platforms. Sixty-two percent (N=57) of the 
participants were recruited online. Baseline disability (ODI/NDI) and pain 
catastrophizing (PCS) scores were similar for both recruitment strategies (p>0.05). 
However, patients recruited from the online strategy were younger (48.7±12.13) 
than the patients recruited from the traditional in-house strategy (59.19±13.38, 
p<.001). Participants recruited by the two approaches may differ in their character, 
as the online recruits need to pro-actively get in contact with the researchers, as 
opposed to being invited to participate.  
One of the most defining differences between regular users (RU) and non-regular 
users (NRU) was the age difference. The RU were approximately 7 years younger 
than NRU (RU=48.7±11.19 years; NRU=55.80±15.30 years, p<.001). This age 
difference may have been associated with users’ respective recruitment strategy, 
with 80% of the RU recruited online, as compared to 56% of the NRU (p<0.01). A 
meta-analysis by Ono et al. (88) identified older patients (age≥60 years) as having a 
better reporting compliance in EMA studies for chronic pain patients using an app or 
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a diary to collect momentary pain intensity ratings over time. The mean age 
(48.70±13.08 years) of the participants from the meta-analysis (88) was similar to 
the mean age of the participants from study II (51.80±13.50 years), suggesting that 
the relevance of age in the compliance rate may reflect the data collection method 
rather than the EMA methodology.  
All participants were invited to complete electronic questionnaires to explore 
usability and acceptance of the pain-mapping app, with an overall response rate of 
88% (N=57). Differences were identified in the device (e.g. mobile, laptop) and the 
pathway used to access the platform between the RU (N=33) and NRU (N=24) (Fig. 
5-2). Additionally, 82% of the NRU relied on the weekly reminders to submit pain 
reports, as compared to 39% of the RU. It is possible that easy and regular access to 
a computer or laptop, for example at work, may influence the reporting compliance, 
as patients reported that drawing their pain on a computer or laptop, rather than a 
mobile phone, was easier (see section 5.3). This would be consistent with the RU 
using the direct URL (uniform resource locator) to access the app. 
 
Figure 5-2. Differences in digital device use and access path to the digital pain-mapping 
app. Fifty percent (N=17) of the regular users accessed the pain-mapping app from their 
computer or laptop, as compared with 40% (N=10) of the non-regular users. Regular users 
did not rely on the weekly reminder to submit the pain reports as much as the non-regular 
users. URL: uniform resource locator. 
RU and NRU had similar scores in the SUS and mTAM questionnaires (p>0.05). 
However, differences in the pain experience provided insights into the compliance 























8073.5) than NRU (3221 pixels IQR 4925, p<0.01). Furthermore, pain intensity was 
lower for RU (5.8± 2.73) than the NRU (6.30 ± 2.3, p>0.01). These results show that 
pain extent, rather than pain intensity, as well as age, are factors influencing the 
reporting compliance rate. These results suggest, that the pain-mapping app was 
likely viewed as a useful tool to communicate pain extent.  
A logistic regression was unable to predict the probability of better reporting 
compliance in relation to the severity of the pain symptoms, including current pain 
intensity ratings, extent, and disability (ODI/NDI) scores at baseline. Further 
analysis revealed that differences identified between RU and NRU in pain intensity 
and extent, may not be clinically relevant. The eCAS intensity ratings difference of 
0.3±0.5 points (p<0.01), out of 10, is less than the recommended 2 points or more, 
out of 10, to be considered clinically significant (179). Visual assessment of digital 
pain drawings representing the mean number of pixels for the RU and the NRU, 
suggest that statistical differences were unlikely to be clinically relevant. Fig. 5-3 
shows that clinical decisions cannot rely solely on the pixels accounting for the pain 
extent. Distribution also has an influence and needs to be considered, simultaneously 
with extent, during the clinical decision-making process. To date, it is unclear how 
much the pixel count needs to change to achieve clinical significance. Additionally, 
the relevance of the pain extent and distribution may differ based on the location, as 
shown in fig. 5-3. Therefore, digital body mapping can provide relevant detailed 
information about extent, distribution, and location to assist the clinical decision-
making process.  
 
Fig. 5-3. Examples of four (A-D) pain drawings showing how pain extent and distribution 
should be simultaneously considered in research and clinical settings. The pain extent, as 
measured by the number of pixels, in figures A and B, as well as in figures C and D may not 
be statistically different. However, the varying pain distribution among figures can have 
different clinical relevance. 
B) 1946 pixelsA) 1250 pixels C) 4209 pixels D) 4471 pixels
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5.2 BARRIERS OF USE FOR DIGITAL PAIN MAPPING 
The previous section described the factors influencing the compliance rates for the 
digital pain-mapping app. Exploring barriers of use may also reveal valuable 
information to develop feasible strategies to improve the compliance rate in 
prospective pain mapping studies. Furthermore, these strategies may also be utilized 
in the clinical setting to improve compliance in symptom tracking and monitoring.  
Patients completed a Navigate Pain-specific electronic questionnaire at the mid- and 
endpoints of the study. Approximately 70% of the RU (N=24) and 60% of the NRU 
(N=15) rated the pain-mapping app, as easy, or very easy to use in general. 
Subsequently, patients were asked what made the pain-mapping app easy or difficult 
to use. Representative responses are summarized and transcribed from Danish to 
English in table 5-2. Additionally, to understand the reason behind the poor 
compliance, the NRU were asked why they did not submit pain reports regularly. 
None of the NRU selected the options “I’m not interested any more” or “I did not 
have time”, as the reason for poor reporting compliance. Forty-five percent (N=10) 
selected “forgetfulness”, whereas 13% (N=3) selected “too much” (N=2), or “no 
pain” (N=1) as reasons for poor compliance. The remaining 41% (N=9) selected 
“other”. Therefore, understanding the patients’ motivation to complete pain reports 
may be useful to optimize the compliance rate. This suggests, further studies are 
necessary to understand compliance behavior. 
Table 5-2. Selected comments describing the digital pain-mapping app as easy or difficulty to 
use, from patients with non-malignant chronic spinally referred pain (N=57). 
Easy to use Difficult to use 
-Reasonably easy after using it a few times. -A little difficult to draw. 
-Easy to handle. -Difficult to understand the symbols. 
-There is a good user guide. -Hard to get started. 
-Nice. Reasonably straight forward. -Hard to draw accurately. 
-It is very clear and easy. A child would 
almost be able to   use it. 
-Seems to be missing some descriptors such 
as electric shock. 
-It is intuitive. -The save button is not easy to find. 
-You can draw the pain with the mouse. -Too small to draw on a mobile phone. 
-Good educational tool. -The symbols make no sense. 
-It is easy to erase if you draw incorrectly. -Difficulty using the mouse to draw the pain. 
-You can draw directly on the picture.  
 
Barriers of use related to technical aspects where identified. These technical 
difficulties included difficulties to register and log in, unable to receive reminders, 
and unable to zoom over a desired body region. Furthermore, the cause of 92% 
(N=12) of the dropouts were technical difficulties with the login process into the 
pain-mapping app. Some of these technical difficulties were due to using outdated 
web-browsers, as the pain mapping software is web-based and not a native mobile 
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app. This means the user logs on to a web page to perform pain mapping, not by 
opening an app installed on a mobile phone. A web app requires no personal 
information from the users and updates can occur more quickly. However, 
compatibility and display issues can pose as limitations. An in-depth comparison of 
advantages and disadvantages of the mobile versus web-apps are beyond the scope 
of the thesis; however, interpretations of the results should consider that some 
dropouts were due to technical barriers and with further development can be 
overcome.  
Three factors were identified to have influenced the digital pain-mapping reporting 
compliance: (1)  technology literacy, described as familiarity with the digital device 
used and navigation of websites, (2) the patient’s motivation to use the pain-
mapping app, and (3) a deep understanding of the user journey map from log in to 
the submission of the pain reports. Therefore, clinicians and researchers alike, need 
to consider the patients digital technology literacy when using digital health 
solutions. Additionally, digital health developers need to consider the users digital 
journey map to maximize compliance rates. 
In this section, we have discussed the factors influencing and the barriers of use of 
the pain-mapping app. However, despite all patients receiving the same information 
and instructions on how to complete the digital pain drawings, an unexpected 
amount of differing drawing styles or behaviours emerged within the pain drawings 
data set. It remains unclear whether these differing drawing styles represent a poor 
drawing technique or skills, result from a misinterpretation or misunderstanding of 
the drawing instructions, or represent an individual’s interpretation of the pain 
experience (fig. 5-4). Therefore, it is essential to deliver standardized and clear 
instructions of use to minimize communication barriers due to misinterpretations 
and, misunderstandings (46).  
 
Fig. 5-4. Illustrative representation of different pain drawing techniques. All patients were 
asked to complete pain drawings by filling out the area of pain. Patients expressed their pain 
by colouring a defined body location by using (A) different size dots spread over the body (B), 
fine lines, or (C) a combination of dots and lines (D).  
D) MixedC) LineB) DottedA) Filled
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5.3 A PATIENT’S PERSPECTIVE: SUGGESTIONS FOR 
IMPROVEMENT AND CLINICAL USE:  
At the end of the data collection period (week 12), all RU and NRU (N=62) were 
asked to complete an electronic user-experience (UX) questionnaire about using the 
pain-mapping app. Specifically, patients were asked to provide suggestions on how 
the app could be improved, how to reduce forgetfulness to improve compliance, and 
their opinion regarding the clinical usefulness of the digital pain reports. Similar to 
the usability and acceptance questionnaires acquired mid-way, patients received a 
small monetary compensation upon completion of the UX questionnaire. However, 
only 23% (N=14) responded. Table 5-1 summarizes the feedback. The suggested 
improvements relate to technical issues and education about pain self-management. 
The technical issues were forwarded to the pain-mapping app developers to improve 
the UX and user interface. The suggested pain self-management improvements 
including automatic comparison between consecutive pain drawings, and 
identification of pain distribution patterns to suggest potential causes and treatment 
options. These suggestions would correspond with the “rapid feedback” strategy to 
improve or maintain reporting compliance (see section 5.1.), as well as the patients 
desire to self-manage their pain. Additionally, this feedback identified a discrepancy 
between patients who want less quality descriptors available, and those who want 
more descriptors, as well as emotional descriptors. 
To reduce the forgetfulness described as a reason for poor compliance in the NRU, 
suggestions consisted of notification messages and a reward point system. The 
reward system would be similar to the concept of “rapid-feedback” suggested by 
Ono et al. (88) to improve compliance. For example, using positive reinforcement 
strategies, this reward system could be a scale showing how good the individual’s 
compliance is in relation to a group or the award of “digital badges” for achieving 
pre-set compliance milestones. Lastly, the majority of patients considered pain 
mapping as a useful tool to track and communicate their pain with healthcare 
professionals. However, the users expressed concerns about the limited time 
available during consultation, and the use of clinical time that would be needed to 







Table 5-1. Selected comments describing improvement, motivation techniques, and perceived 
clinical usefulness of the digital pain-mapping app in patients with non-malignant chronic 
spinally referred pain (N=14). 




-Information about the 
symptoms and pan relief 
options. 
-Make it a downloadable app 
for ease of access and set up 
notifications. 
-Yes. Clinicians only ask 
about the pain I have at that 
time and not overall. 
-Improve the pain intensity 
scales. 
-Maybe something with a 
point system. 
-No, but it helps me to 
communicate my pain. 
-An automatic comparison 
between pain drawings. 
-Send reminders every day 
until answered. 
-Yes, it is easier than a pain 
diary. 
-More pain descriptors.  -Send a SMS. -Clinicians have no time. 
-Have fewer words to 
describe pain. Now it is too 
confusing. 
-Perhaps, if the drawings 
were used for treatment, it 
would be better. 
-Yes, it would provide an 
understanding of the pain 
variations. 
-Add words to describe 
emotional and physical 
feelings, such as fatigue. 
 -Yes, it is easier to show 
what is wrong and where the 
pain originated. 
-Options to modify the saved 
pain drawings. 
 -Yes. Helps to remember 
where and when it hurts.  
-Provide possible causes for 
the changes in pain to learn 
about your pain. 
 -Yes. To see the links 
between the pain and any 
training or treatment. 
-Improve the zoom feature.   
 
5.4 EXPLORING NOVEL PAIN METRICS FOR THE CLINICAL USE 
OF DIGITAL PAIN MAPPING  
Symmetrical pain patterns, as assessed using pain drawings, have been used in low-
back pain with distal pain referral, to differentiate between somatic and radicular 
pain (180). However, the assessment of the spread and consistency of pain 
distribution over time, may be a more objective outcome to assist in the clinical 
decision-making process. Therefore, novel pain metrics were used to determine a 
consistency index and the changes of pain distribution spreading over time using 
digital pain drawings. 
5.4.1 ASSESSMENT OF THE PAIN AND DISCOMFORT 
CONSISTENCY 
Pain distribution is a relevant tool to support the clinical decision-making process 
(see section 1.1). Pain and discomfort distribution consistency over time or lack 
thereof, may offer a clearer picture of the pain condition. For example, a diagnosis 
of neuropathic pain includes an assessment of neuroanatomically plausible pain 
distribution consistency (181). Furthermore, the identification of a lack of pain 
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distribution consistency can be used as to  identify other causes of pain such as, 
malignancies (182), appendicitis (183), or aneurysm (184). Therefore, a measure of 
consistency, such as a pain distribution consistency index could capture the 
distribution changes over time. A higher consistency index would indicate similar 
pain and discomfort distribution patterns, as represented in the pain drawings. 
The Jaccard index (see section 2.3.1), was used to assess similarities in pain and 
discomfort distribution among pain drawings and determine a distribution 
consistency index. The Jaccard index was calculated between two consecutive 
weekly pain drawings for each of the patients. Results showed that consecutive 
weekly pain drawings were similar, suggesting pain and discomfort distribution 
consistency on a weekly basis, at a group level. However, a more clinically relevant 
distribution consistency index would assess changes in consistency over a longer 
period, such as from week one to week four, and so on (see section 7.3).  
The Jaccard index has been used to assess the level of pain distribution similarity 
between two pain drawings (75). However, the use of this measure can lead to 
misinterpretations, as it may miss development of pain in a new area, or a change in 
the shape of the pain spread from a large centralized area in the buttocks to a thin 
line from buttocks to foot. Furthermore, the Jaccard index only assesses the 
similarity between two pain drawings at specific time points, missing spatiotemporal 
changes in pain distribution over time. The development of novel pain metrics to 
assess consistency may be a relevant evolution for the clinical application of digital 
pain mapping. The availability of a pain distribution consistency index during the 
patients’ assessment may provide a novel relevant outcome during the clinical 
decision-making process. 
5.4.2 VISUAL ASSESSMENT OF THE OVERALL PAIN 
SPREAD  
To assess the areas where pain and discomfort was more frequently reported, as well 
as the bodily spread, heat maps and contour overlays were created. Only pain 
drawings of the posterior view were explored for the primary pain sites (cervical and 
low-back pain) and presented for male and female. 
Heat maps are used to display frequency visually. The heat maps make for an easy 
visual comparison of common pain locations (18,76). Therefore, to visualize the 
frequency of pain, dull aching, stabbing, burning and numbness sensations, heat 
maps were generated using pain drawings from study II. These heat maps revealed 
that females with low back pain reported larger patterns of pain that referred from 
the low-back and lower limb, than the male patients. Additionally, heat maps 
revealed that females with their primary pain site on the low-back reported burning 
sensations more frequently on the hands, whereas the male counterparts reported 
burning sensations more frequently on the feet (Fig. 5-5).   
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Contour overlays revealed that burning and numbness sensations were perceived as 
more localized (Fig. 5-6). Additionally, the contours revealed that pain and 
discomfort were widespread for females, independently of the primary pain site. 
Similarly, males reported widespread pain and those with back-pain did not report 
pain in the arms. These results concur with previous findings suggesting that chronic 
widespread pain is more prevalent in females than males (185,186). 
 
 
Figure 5-5. Pain heat maps generated by pain drawing overlays of patients with non-
malignant chronic spinally referred pain from study II. Pain heat maps generated from 
patients with their primary pain site on the low-back, representing (A) pain and (B) burning 
quality descriptors. The colour gradients indicate the frequency (%) of patients that reported 
pain and discomfort in the specific location. Darker colours represent the most frequently 
reported location of pain and discomfort. Each heat map has a different scale displaying the 
number of participants (N) and the number of pain drawings. 
 
N=10 N=10




Pain drawings=27 Pain drawings=10
N=134 N=115
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Figure 5-6. Contour overlays generated by pain drawings from patients with non-malignant 
chronic spinally referred pain from study II. Contour overlays generated for men, women, 
and primary pain site (A-cervical and B-low-back) separately. None of the male patients with 
the primary pain site on the cervical spine reported burning sensations. 
5.4.3 CONCURRENT PAIN AND DISCOMFORT QUALITY 
DESCRIPTORS 
Patients submitting digital pain reports were able to select among a range of 10 pain 
descriptors, as well as the general descriptor “pain”. While selecting among quality 
descriptors, patients were able to additionally select the intensity of each descriptor 
among mild, moderate, or severe.  
The pain descriptor selection data obtained from the submitted pain reports also 
allows for novel pain metrics to explore the concurrence or likelihood of reporting a 
specific quality descriptor, based on the actual selected descriptors. The clinical 
interest of exploring concurrent pain descriptors can assist towards a condition’s 
quality descriptor pattern prediction and prognosis. 
The frequency of mild, moderate, and severe pain with concurrent descriptors was 
determined to explore quality descriptors reporting patterns. Severe pain was most 
commonly associated with numbness and throbbing. Similarly, patients that reported 










Fig. 5-7. Concurrence of pain and discomfort quality descriptors using digital pain 
mapping. The color segments offer an easy visualization of the likelihood ratios of having a 
second quality (secondary quality descriptor) at the same time as another quality (primary 
quality). The orange segments represent a likelihood ratio greater than 15%, whereas the 
blue segments represent a likelihood less than 15%. The italic numbers represent the number 
of patients with the primary and secondary quality descriptors. 
5.5 LESSONS LEARNT FROM DATA COLLECTION USING 
DIGITAL PAIN MAPPING IN A CLINICAL POPULATION 
Patients recruited online tended to have better retention rates and be more compliant 
than the patients recruited using the traditional in-house strategy. The online nature 
of the study allowed for the creation of more engaging recruitment strategies and the 
development of interactive pathways to deliver information. This pragmatic 
feasibility study of a web-based pain-mapping app identified insights which may 
improve online recruitment strategies and reporting compliance in future studies: 
- Online-related patient recruitment criteria: 
o Regular access and habitual use of a digital device at home and/or 
work. 
o Access to at least one more device than a smart phone, such as 
digital tablet or computer.  
o Technology literacy and confidence in the use of e-mail, the 
different available devices, and different internet browsers. 
o Name the study with an easy to understand name resulting in a 
catchy acronym, easy to remember. Use it in all correspondence. 
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o Researchers should have continuous access to the recruitment 
platforms to offer potential recruits a fast turn-around response 
time. 
 
- Optimization of the online recruitment strategy: 
o Research the social media platform demographic to inform your 
platform selection. 
o Develop a strategy to maximize social media reach by choosing 
your preferred audience. Development of recruitment 
collaborating partners to share and advertise the study online.  
o Creation of a square video format with a maximal duration of 30-
60 seconds and a clear descriptive title. 
o State the key message in lay language, contact details and direct 
access to further information (i.e. website).  
o Official logos and institutional e-mails from the research 
institution should be used to signal safety and credibility. 
o The message to convey should be clear and reinforced with visual 
cues. 
o The first three seconds need to be of impact to catch the attention. 
o The video should have captions. 
o Suggest viewers to tap for sound. 
o The researchers should appear in the video to humanize the 
research.  
o Ease of contact using direct messaging (i.e. Messenger) to the 
platform with a fast response turn-around time. 
 
- Retention and compliance maintenance: 
o Provide the patient with a journey map to level expectations 
regarding frequency and type of data collection and other forms of 
contact. 
o Remind the patient to check the junk mailbox regularly. 
o Development of a reminder system to suit the individual needs. 
o Optimization of the user journey and identification of the patients’ 
motivation, technical challenges, and limitations. 
o Development of positive reinforcement strategies, such as rapid 
feed-back and personalized comments. 
o Rapid response to queries and comments. 
o Personalize feedback using the patients’ name and friendly 
language.  
o Add a photo of the researchers to create familiarity when 
communicating electronically. 
o Use positive reinforcement strategies. 
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The online recruitment strategy required approximately 80 hours of work prior 
involving researchers and videographers. Time for brainstorming, script writing and 
rehearsing to ultimately record a one-minute video, create a flyer and landing page, 
as well as upload one post on Facebook. The video recording and production, as 
well as the printing of the flyers cost a small fee. The flyer had a QR code directing 
the prospective recruit to a landing page. The landing page had information about 
the study and the researchers’ contact details, and no patients were recruited using 
this pathway. The recruitment video reached 15,256 people, had over 5,000 unique 
viewers, and received 281 engagements (clicks, likes, comments and shares) in 
Denmark. The post was shared 91 times. The top five sharing sites included 
physiotherapy clinics, pharmacies, and spinal pain patient groups. In addition to the 
work involved prior recruitment, 10 minutes were required per participant for the 
screening process (8.5 hours).  
In comparison, the traditional in-house strategy required approximately 20 hours 
prior work to develop documentation, and approximately three two-hour-long 
meetings with the Head of Department to explain the study and agree on a 
collaboration. Similarly, the Head of Department used approximately three hours to 
discuss the study with the department staff and other administrative problem 
solving. The invitations to participate were added to the electronic appointment, 
with an estimate of 200 invitations sent, in a six-month period. Each doctor in the 
department used approximately 10 minutes for every one of the 200 potential 
recruits (33.5 hours). If the patient agreed to participate, a further three minutes were 
used to sign the consent form (1.5 hours). These consent forms were then collected 
from the hospital and delivered to the university. It is estimated that the recruitment 
strategy required approximately 100 hours in total. Therefore, the traditional in-
house recruitment strategy had less direct costs, but required more time, effort, and 
resources than the online strategy.  
To gauge success of each strategy, a cost-benefit ratio was calculated using the basic 
hourly salary rate of the personnel and expenses incurred per patient recruited. The 
cost-benefit ratio for the online strategy was approximately 430DKK per participant; 
whereas the ratio for the traditional strategy was calculated as 1200DKK per 
participant. The online recruitment strategy resulted in approximately double the 
number of patients than the traditional in-house recruitment strategy. Additionally, 
patients recruited online had better reporting compliance. Therefore, the online 
recruitment strategy may prove to be more time and cost-efficient than the 
traditional in-house recruitment strategy. 
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5.6 SUMMARY OF THE MAIN FINDINGS STUDY II           
(CLINICAL USE)  
This PhD project (study II) tracked pain and discomfort remotely using a pain-
mapping app, over a prolonged period, in patients with non-malignant chronic 
spinally referred pain. The main findings were: 
• The feasibility of tracking pain remotely in a research project is depending upon 
retention and compliance. Factors influencing compliance are related to the app 
(ease-of-use and usability), as well as to the patients’ motivation and perceived 
benefit.  
 
• Patients with a better reporting compliance rate were younger and had been 
recruited using an online strategy. The online recruitment strategy using social 
media platforms was more time-efficient than traditional recruitment strategies. 
 
• Barriers of use (technical and communication) need to be overcome to improve 
compliance. Additionally, positive reinforcement strategies need to be 
implemented to improve engagement. 
 
• Novel digital metrics were applied as method to quantify pain beyond area 
(pixels) and intensity measures. These metrics included a distribution 
consistency index, frequency and contour maps, as well as concurrent quality 







CHAPTER 6. NOVEL APPROACHES TO 
QUANTIFY CHANGES IN THE 
INTENSITY OF QUALITY 
DESCRIPTORS 
Quality descriptors can help delineate the driving mechanisms of pain (8,9,154), 
reveal symptom progression (2,9), and help to differentiate between nociceptive, 
neuropathic pain, and peripheral neuropathies (11,187–189).  
In the early 1980s the McGill Pain Questionnaire (MPQ) (13) was developed  to 
assess the quality and the intensity of pain. The MPQ consisted of 78 qualities to 
describe the sensory and affective dimensions of pain, as well as a body chart. This 
original version of the MPQ was later modified to and named the Short-form MPQ 
(14), where the number of pain descriptors was reduced to 15. Additionally, the 
intensity of each of those 15 descriptors was rated as none, mild, moderate, or 
severe. Furthermore, the Short-form MPQ (Short-form MPQ-2) was revised and a 
total of 22 pain descriptors were included alongside a 0-10 NRS (111). Similarly, 
the Pain Quality Assessment Scale (PQAS) (190) rates the intensity of 16 different 
pain qualities, as well as the level of unpleasantness, depth, and frequency. The 
sensory perception of a quality descriptor is influenced by self-awareness, language, 
and prior experiences (191,192). Changes in sensory perceptions in response to a 
stimulus are assessed using psychometric tests. However, patients with language 
barriers and cognitive limitations may be challenged to identify a descriptor to 
match the perceived sensation. 
Digital health solutions have taken a step beyond the current psychometric tests to 
visualize and quantify sensory perceptions (193,194). The web-based painQUILT 
app (193,195) uses illustrations or icons to represent the sensory perception. For 
example, an icon of a hammer to represent a pounding sensation, or a sword to 
represent stabbing. The Painimation App uses short motion graphics or animations 
of an illustration with sound effects, instead of using a verbal descriptor to describe 
the sensory perception (194). For example, Painimation uses an animation of 
electricity (an angular line moving like a lightning bolt, accompanied by a mains 
hum sound) to represent the sensation of electrifying. Both apps use an illustration 
(animated or not) to overcome the language barrier. However, identifying an 
illustration (i.e. a hammer) with the associated perception (i.e. throbbing descriptor) 
also requires self-awareness and prior experiences. Additionally, both apps quantify 
the intensity of the sensory perception using a rating scale, as well as the percentage 
on the body chart.  
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Study III (77) aimed to assess the relationship between sensory perceptions and a 
range of non-painful transcutaneous electrical stimulation. The digital pain-mapping 
software Animate Pain was used to determine changes in electrically evoked sensory 
perceptions by adjusting a tingling animation (see section 2.3.2 for a description of 
study III methods).  
6.1 QUANTIFYING SENSORY PERCEPTION USING SELF-
ADJUSTED ANIMATIONS (STUDY III) 
Participants received a range of randomized transcutaneous electrical stimulations 
(2, 3, 3.5, 4, 4.5, 5, 5.5 and 6mA) of four seconds duration each. This range was 
repeated three times to elicit sensory perceptions to healthy participants. Following 
each stimulation, participants adjusted two digital visual analogue scales (dVAS) to 
modify the density and speed of the dots from a tingling animation in real-time.  
Study III (77) revealed that participants (N=32) systematically adjusted the density 
parameter of the tingling animation following in a correlated fashion to the intensity 
of the electrical stimulation (fig. 6-1, A-B). No associations were found for the 







Figure 6-1. Relationships between electrical stimulation intensity, perceived intensity 
ratings, and density (N=32). Systematic increases in perceived intensity ratings and density 
for the tingling animation were associated with increases in electrical stimulation intensity 
for (A, B) the complete data set (N = 641 perceived stimulations), (C, D) the data sub-set 
representing perceptions described as tingling (N = 252 stimulations), and (E, F) the data 
sub-set representing the perceptions not described as tingling (N = 389 stimulations). 
Significance (*) adjusted for multiple correlations set at P<0.001. Box and whiskers 
represent the median (line), maximal, and minimal values. Reproduced with permission 
(Galve Villa et al., 2020) 
Tingling was most frequently selected with the low electrical stimulation range (3 to 
4.5mA), with a transition towards the more frequent use of stabbing, drilling, and 
sharp sensations in the upper electrical stimulation range (4.5 to 6mA) (fig. 6-2). 
These results suggest that the low electrical stimulation range was appropriate as an 
experimental tingling model. 
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Figure 6-2. Frequency of quality descriptors selection associated with the different 
electrical stimulations. The bright colours represent the descriptors most frequently selected 
during study III. Tingling was most frequently selected from 3 to 4.5mA. Stabbing and drilling 
had the largest increase in frequency from 4.5 to 6mA, as the frequency of tingling decreased. 
Results from the density adjustments and perceived intensity ratings, as shown in 
figure 6-1, may be explained by the changes in the descriptor selection. Panels C to 
F from figure 6-1 show a trend (not significant) in density and intensity ratings as 
the electrical stimulation increases from the data subsets of the stimulations 
described as tingling (C-D) and the remaining stimulations (E-F). However, the 
complete data set (A-B) shows a significant adjustment in density and intensity 
ratings associated with an increase in stimulation. These results may be explained by 
the descriptors numbness and itchy. Even though tingling is the most frequently 
selected descriptor in the low stimulation range, its frequency decreases as the 
stimulation intensity increases. However, the selection frequency of numbness and 
itchy has the opposite pattern, increasing from 3-4.0mA. Therefore, the descriptors 
numbness and itchy from the non-tingling data sub-set are, perhaps, the cause of the 
different density and intensity ratings results among the complete, tingling, and non-
tingling datasets.  
The MPQ (13,196) characterizes descriptors into sensory, affective, and evaluative 
class and 16 subclasses. Within each subclass, the position of each descriptor is 
based on the relative intensity ranking within that subclass. For example, “hot” 
appears earlier than “scalding” in the thermal subclass list, as “hot” is ranked as a 
less intense sensation than “scalding”. This descriptor relative intensity ranking 
suggests a sensory hierarchy. Our results show a transition from tingling, numbness, 
and itchy towards drilling, stabbing, and sharp, from the lower to the higher 
electrical stimulation intensities. These results suggest a hierarchical relationship 
among these descriptors. In the clinical practice, this hierarchical transition may be 
useful to suggest disease progression when, for example, a patient reports a tingling 
sensation has changed to a stabbing sensation. Therefore, the concept of a hierarchy 
in quality descriptors may be relevant as a tool to identify progression or regression 


































of pain and discomfort symptoms, supplementary to the concurrent quality 
descriptors described in section 5.3.3. 
The use of the self-adjustable animation revealed that the density parameter was 
associated with changes in sensory perceptions. These animations may be useful to 
quantify changes of sensory perceptions, if they can help to overcome language and 
cognitive barriers. However, this will need further research and validation. 
Moreover, the assessment of changes in sensory perceptions over time can offer a 
new temporal dimension into pain mechanisms and assist in the clinical decision-
making process. 
6.2 PARTICIPANTS’ FEEDBACK ON THE ANIMATION  
Semi-structured interviews in study III (77) revealed the participants’ experience 
and insights into the adjustment of the tingling animation to visually represent a 
sensation. The responses obtained from the interviews were transcribed, coded, and 
grouped into three themes (table 6-1). 
Table 6-1. Selected comments describing the appropriateness of the animation, usability 
issues from the Animate Pain app, and suggestions for improvement (N=34). (Reproduced 
with permission Galve Villa, 2020). 
Appropriateness of the 
animation 




-Not happy with the speed 
parameter. 
-The speed was confusing 
and difficult to adjust. 
-It should have an image of 
the whole hand. 
-It represents fine the 
sensations of tingling I felt, 
but if I see it out of context, I 
would not think of tingling. 
-The name “speed” is not 
appropriate, and I found the 
scale very confusing to 
adjust. 
-I would have liked to be 
able to change the shape of 
the dots to something sharp, 
like a triangle. 
-The animation represents 
well what I felt. 
-Not user-friendly. The grey 
colours, the scales. 
-Change the colour so it is 
easier to see the dots. 
-Good baseline animation for 
this study. 
-Difficult to put the sensation 
onto the image. 
 
-Neither animation nor 
canvas matched the 
sensation. 
-I liked the hand 3D image.  
-Easy to adjust.                      
-It is fine. Works well. 
 
 
6.2.1 THE APPROPRIATENESS OF THE ANIMATION 
Most participants had a good impression about the suitability of the tingling 
animation (“Good baseline animation for this study”, “The animation matched the 
sensation”). Whereas some participants reported opposite comments (“It didn’t fit”, 
“Neither the animation nor the canvas matched the sensation”), suggesting the 
animation was only suitable to represent a tingling sensation. 
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6.2.2 THE USABILITY OF THE PAIN MAPPING 
SOFTWARE 
Overall, most of the participants identified difficulties adjusting the speed dVAS 
(“The speed was confusing and difficult to adjust”, “The name speed is not 
appropriate and is confusing”, “Not user-friendly”). Furthermore, some participants 
reported difficulty adjusting the dVAS as the dots from the animation were difficult 
to see due to a poor colour contrast (grey dots on grey canvas). A brighter room or a 
larger screen may have offered an improved visibility. Nonetheless, most of the 
participants reported that adjusting the density parameter as intuitive.  
6.2.3 SUGGESTIONS FOR IMPROVING THE SOFTWARE 
Participants most commonly recommended changing the grey colour range of the 
dots and the canvas, having a canvas with the dorsal aspect of the hand, and 
modifying the speed dVAS with a more intuitive rating scale. An interesting 
recommendation was to enable a feature to change in the animation’s shape. Such as 
a feature would change the animation’s dots to, for example, triangles to represent 
the transition from tingling to stabbing. 
6.3 SUMMARY OF THE MAIN FINDINGS FROM STUDY III 
(ANIMATIONS TO QUANTIFY DESCRIPTORS) 
Study III used state-of-the-art software allowing momentary adjustments of an 
animation to quantify changes in perceived intensity, following a range of 
transcutaneous ES. The animation aimed to visually represent a sensation of tingling 
with dots appearing and disappearing. The adjustable features from the animation 
modified the density (number of dots per random unit) and the speed at which the 
dots appeared and disappeared. The findings from study III revealed that: 
• Increases in the animation density were associated with increases in the perceived 
intensity ratings and intensity of the electrical stimulation. These findings imply 
that self-adjustable animations may be a useful method to quantify changes of pain 
and discomfort quality descriptors. 
 
• Increasing the intensity of the ES revealed a hierarchy in quality descriptions 
where perceptions transitioned from tingling, numbness, and itchy to stabbing, 
drilling, and sharp. This hierarchy may be useful to clinically assess the 
progression or regression of pain and discomfort. 
 
• Self-adjustable animations may be a useful tool to assess sensory perceptions 
beyond pain, overcome language and cognitive barriers, and represent a further 




CHAPTER 7. CHALLENGES AND 
LIMITATIONS OF DIGITAL PAIN 
MAPPING 
Digital pain mapping offers advantages as compared to pen-to-paper pain drawings, 
such as improving the systematic quantification of pain, and the momentary 
ecological acquisition of digital pain biomarkers. However, the use of the digital 
pain-mapping app in patients with non-malignant chronic spinally referred pain was 
met with challenges and limitations.  
7.1 METHODOLOGICAL CHALLENGES  
The ability to accurately represent the distribution of a pain perception onto a body 
chart is a basic limitation when using a pain drawing, as the drawing may be 
influenced by the individual’s body image (197,198) and drawing ability (143). This 
limitation is equally present when using pen-to-paper and digital pain drawings. 
Currently, it is unknown whether the individuals’ drawing ability will improve by 
completing pain drawings repeatedly over time, due to motor and cognitive skills 
improvement with repetition (199,200). Additionally, it is unknown whether 
improving the digital drawing equipment from a mouse or finger-tip to an S-pen, or 
modifying the body chart to a more realistic 3D avatar (62,201,202), would 
influence the drawing ability. Challenges and limitations related to the individual 
studies are discussed in the following sections. 
7.1.1 ASSESSMENT OF MOMENTARY PAIN AND PAIN 
RECALL ACCURACY (STUDY I) 
Participants from study I were asked to report the evoked momentary pain intensity 
every 30 seconds from onset until pain cessation, following an injection of HS. 
Additionally, participants were randomized into a drawing or a non-drawing group. 
Participants from the drawing groups captured the momentary pain intensity and 
distribution simultaneously. Seven days after the injection of HS, all participants 
were asked to recall the evoked peak pain intensity and extent (see section 4.1). 
The number of participants in each of the four groups may not have been large 
enough to identify spatiotemporal differences. The high variability of the size of the 
momentary pain area and the lack of more intense momentary pain may have limited 
the ability to detect statistical differences (see Fig. 3.1). Specifically, the momentary 
pain distribution was only captured on 13 participants for each dose. A post-hoc 
effect size calculation for the size of the peak pain (PP) area showed that 10% of the 
size was attributable to the group, suggesting the size of the study was 
underpowered. 
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The pain area recall accuracy for the non-drawing groups was assessed using the 
extent of the peak pain area and the pain distribution from the drawing groups, as a 
reference. The use of the drawing groups’ data as a reference may have influenced 
the recall accuracy assessment between drawing and non-drawing groups. Therefore, 
undermining the results suggesting a lack of influence in pain recall by the repeated 
drawing task. A crossover study design, with four sessions and all subjects 
participating in drawing and non-drawing groups may help overcome this limitation. 
7.1.2 LONGITUDINAL STUDIES USING ECOLOGICAL 
MOMENTARY DATA ACQUISITION (STUDY II) 
The advantages of acquiring ecological momentary digital pain biomarkers (see 
section 1.3) raise methodological challenges due to the lack of standardized quality 
pain reporting (46,90,203). The quality of the data acquired is a common challenge 
for longitudinal studies relying on patients to submit information. For example, in 
study II some patients submitted digital pain reports as requested (weekly), whereas 
other patients submitted the pain reports too often (pockets of data overload) and 
others not often enough (pockets of missing data). Results from study II also show 
differences in the device used (see section 5.1), as well as the quality (drawing style) 
of the pain drawing (see section 5.2) among patients. Lastly, the comments provided 
during pain reporting (section 3.4) highlight differences in the reporting context 
(location and environment). Optimizing data quality may improve the accuracy of 
the results obtained using remote pain mapping and tracking in future clinical 
research studies.  
The lack of contextual information about factors that may influence the patients’ 
pain experience, such as treatment and activity levels, was not systematically 
collected during study II. The contextual information provided by the patients’ 
comments (see section 3.4), suggests that detailed information about the individual 
patient’s social environment may open a window to understand improvements in or 
worsening of pain symptoms. For example, pain may improve after a specific 
treatment in a patient with a sedentary lifestyle. This pain improvement may lead to 
a subsequent improvement in mood and an increase in physical activity. This 
increase in activity can, subsequently, provoke an increase in pain compelling the 
patient to regress to sedentarism, commencing a “yo-yo effect” or vicious cycle of 
pain and inactivity (204,205). Awareness of the causes triggering this vicious cycle 
may contribute to a break in this behavior, leading to better pain self-management. 
Longitudinal studies, such as study II, also have limitations regarding the 
interpretation of results due to confounders (206–208). In study II, time-varying 
confounders, such as a drawing learning curve, motivation, and external stressors, 
may have influenced the interpretation of the results. Likely, these time-confounders 
have influenced the weekly pain fluctuations identified in study II (see section 3.2). 
For example, feedback from patients (see sections 5.2 and 5.3) revealed that the 
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zoom and the brush thickness features from the pain mapping app were difficult to 
use on a small screen (i.e. mobile phone). A device change from a mobile phone to a 
tablet or laptop during the study, may have improved the usability of the above-
mentioned features, therefore, improving the detail of the pain distribution. 
Similarly, contextual changes, such as holidays, a different bed, a new job, and 
social events can influence the access to a specific device, the reporting frequency, 
and the experience of pain, as reflected in the patients’ comments (see section 3.4). 
These examples show the relevance of how longitudinal data collection should be 
standardized, when using digital pain mapping in research studies. Standardizing 
data collection would involve stricter inclusion criteria, with patients committing to 
submit pain reports at a specific time and frequency, using a pre-set-up device 
provided by the researchers. Additionally, the development of educational materials, 
such as a short online interactive course highlighting the common issues identified 
by study II, instructions about the pain reporting frequency and reminders 
throughout the study, would align expectations among patients and researchers. 
Furthermore, developing notification methods to identify pain drawings with 
possible errors (i.e. drawing a circle around the pain location, rather than drawing 
the size of the area of pain on the location) would also optimize data quality.  
The lack of standardization appears to be common in studies using digital health for 
data acquisition. A recent review assessed 23 validation studies for 58 wearable 
devices using a common data collection method (accelerometry) to monitor and 
report physical activity (209). This review highlighted the variety of methods and 
reporting outcomes used, some reportedly inappropriate and incomplete, and 
suggests the need for guidelines to enhance the methodology for digital health 
studies (209).  
7.1.3 ANIMATIONS FOR THE QUANTIFICATION OF 
CHANGES IN QUALITY DESCRIPTORS (STUDY III) 
Study III used a pre-determined animation to visually represent the sensations 
evoked by a range of electrical stimulation intensities. Therefore, participants were 
limited to a single animation to depict a range of evoked sensations. Furthermore, 
participants were limited to represent the spread of the evoked sensations on the 
volar aspect of the hand, unable to capture any sensations perceived in the dorsal 
aspect and underestimating the area of spread. Therefore, the results may have 
reflected a lower size of sensation area. However, results showed a trend of localized 
spread, rather than referred, evoked sensation. This trend suggests that the lack of 
area reporting in the dorsal aspect of the hand (referred pain) may not have 
influenced the results. 
There were usability issues with the speed dVAS identified during the feedback with 
the participants at the end of the session (see section 6.2). The poor usability of the 
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speed dVAS may have driven participants to adjust the density dVAS, due to a lack 
of other modifiable features. Modifying the speed dVAS to a more intuitive format, 
as well as the addition of novel shape-adjusting features, may improve the accuracy 
of the results in further studies.  
7.2 ANALYTICAL LIMITATIONS 
Study II used digital pain reports to assess changes in pain and discomfort intensity 
and extent over time (see section 3.2). Patients were able to report distribution using 
11 different quality descriptors. The pain and discomfort extent, as assessed in 
pixels, was calculated by the sum of all the quality descriptors used in the weekly 
pain report. However, some pain reports may have had a quality descriptor location 
overlap, resulting in an overestimation of the pain and discomfort extent. 
A pain distribution consistency index was explored as an advanced tool to assist in 
the clinical decision-making process (see section 5.4.1). However, the Jaccard index 
results have no clinical implications and the results may be misleading. For example, 
a high Jaccard index could suggest similarities between two pain drawings with 
equal pain areas in general but missing other small pain areas with clinical 
implications (see fig. 5.3). Furthermore, in study II, the Jaccard index assessed the 
similarity in consecutive pain drawings, determining that pain and discomfort 
distribution does not change weekly. This suggests that the Jaccard index was not an 
appropriate measure to assess changes of pain distribution over time.  
7.3 SUMMARY OF THE MAIN FINDINGS (CHALLENGES AND 
LIMITATIONS) 
Data collection using digital pain mapping can lead to a range of methodological 
challenges and limitations. This PhD thesis revealed the following challenges and 
limitations: 
• Study I showed that repeated pain drawings did not influence the accuracy of the 
pain distribution recall. However, the assessment of the pain recall accuracy in the 
non-drawing groups may have been influenced by comparing the non-drawing 
groups’ recalled pain drawings with the drawing groups’ baseline pain drawings. 
Therefore, the influence of the repeated pain drawing task may have been 
underestimated. 
 
• Study II identified methodological challenges due to the lack of standardized 
acquisition of digital pain biomarkers. Additionally, study II highlighted the need 





• Study III explored the ability to perceive and visually represent quality descriptors 
using a self-adjustable animation. However, usability issues related to the speed-
adjusting scale may have limited the results. 
 
• The combination of further development of digital health technologies and deeper 
understanding of the user journey and motivation, as well as an increase in the 
understanding of the challenges and limitations met by different users (patients and 






















CHAPTER 8. CONCLUSIONS AND 
FUTURE PERSPECTIVES 
The current PhD thesis has addressed three specific objectives: (1) identify and 
quantify spatiotemporal patterns of experimental and clinical pain intensity, extent, 
and distribution using digital pain-mapping apps, (2) quantify changes in 
experimentally evoked tingling sensations using adjustable animations, and (3) 
determine barriers of use, challenges, and limitations of the different digital pain-
mapping technologies utilized.  
8.1 CONCLUSIONS 
Study I showed dose-response differences of hypertonic saline (HS) evoked-pain 
intensity, extent, and distribution over time; whereas no differences were identified 
at peak pain. Pain extent was revealed as a less susceptible outcome to be influenced 
by pain catastrophizing and perceived stress. Furthermore, study I determined that 
continuous pain reporting using digital pain drawings does not influence the pain 
recall accuracy 7-days later. Therefore, these findings support the use of digital pain 
mapping to capture momentary changes in pain continuously over time. This study 
implies the importance of pain extent, as well as, pain intensity in the assessment of 
experimentally evoked pain. These results should be considered in the 
methodological planning of future studies using HS. 
Study II showed fluctuations in intensity and extent in clinical pain, as assessed 
remotely using digital pain drawings. This study showed that chronic pain may not 
be as stable as may have been previously thought, and that identifying contextual 
factors that increase or decrease the pain may be the key to better management. Pain 
extent was found as being less susceptible to pain catastrophizing, similarly to the 
findings from study I. However, study II showed that pain extent alongside pain 
distribution provided clinically relevant data for the pain assessment. Patients’ 
usability assessment suggested that digital pain mapping was a useful and easy-to-
use pain communication tool. Therefore, these findings further support digital pain 
mapping as a clinically relevant tool for the assessment and communication of pain. 
Study II also identified better compliance rates in younger patients recruited from an 
online strategy. Online recruitment was revealed as more time and cost-efficient 
than the traditional in-house recruitment strategy. A checklist was devised for the 
implementation of online recruitment strategies in future research. This study also 
highlighted the importance of understanding the patients’ motivation to optimize the 
response compliance rate. These results support the further development of pain 
mapping technology and exploring its implementation in healthcare settings. 
Lastly, study III took a step beyond the classic pain assessment and showed that 
self-adjustable animations may be a useful tool to quantify changes in sensory 
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perceptions beyond pain. Additionally, results from study III support the concept of 
a pain quality hierarchy which may be useful to clinically assess the progression or 
regression of pain and discomfort.  
In summary, the three PhD studies contribute towards the use of remote digital pain 
mapping and tracking to obtain a more detailed picture of the patients’ pain 
experience. Digital pain mapping can utilize novel digital pain metrics to assess and 
quantify spatiotemporal patterns of pain and discomfort distribution. These three 
studies create a platform to visually communicate pain, using self-adjustable 
animations, to map and track changes in ecological momentary pain and discomfort 
over prolonged periods. Therefore, digital pain mapping can optimize patient-
clinician communication of pain and discomfort. 
8.2 FUTURE PERSPECTIVES 
The limitations and challenges outlined in this PhD should be used to better inform 
current and future digital health tools to meet the user’s needs. This PhD project 
underscores the relevance of user-centred design principles to understand the 
perceived user benefit (patient and clinician) and user journey at the outset. 
Integrated user-centred methodologies, such as  design thinking strategies and co-
development approaches during the development process (210,211) may facilitate 
compliance, adoption, and implementation.  
Prospective developments of digital pain mapping may involve the use of 360° 3D 
body charts, including a non-binary gender chart option, to allow the capture of the 
pain and discomfort distribution, without spatial limitations, as it spreads around the 
body. This body chart development could also make use of augmented or virtual 
reality (201) to capture pain and discomfort distribution, as well as the depth of pain. 
The use of augmented or virtual reality would allow for self-adjustable animations, 
rather than the use of colours or intensity rating scales, to quantify changes in pain 
qualities. While these virtual body charts represent a technology advancement, they 
would also present technological, accessibility, and methodological challenges.  
Machine-learning is a powerful pattern finder and claims to be useful to predict, 
personalize and, in some cases, prevent pathological processes (212). Future 
analysis of digital pain drawings may also benefit from machine-learning models. 
For example, machine learning could improve the quality of the pain drawings by 
automatically filling out areas of pain from a circle outline, therefore allowing a 
more accurate account of the pain extent, as assessed in pixels. Additionally, 
applying machine learning may reveal spatiotemporal patterns of pain and 
discomfort that may help to manage and predict prognosis in pain conditions 
(91,213). However, machine-learning models can give false positive presenting 
results that can be misinterpreted, leading to overdiagnosis or misleading 
conclusions (214,215). The combination of different pain-mapping technologies to 
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allow remote ecological momentary assessment (EMA) and the use of animations to 
capture pain and discomfort over time, together with machine learning, has the 
potential to disrupt and advance pain assessment in the clinical and research fields. 
The combination of EMA and monitoring, machine learning analysis, and clinician 
interpretation may be the next step for pain management and mechanism-based 
research. A clinical decision-making process, supported by digital biomarkers, may 




















    1.  Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, et al. The 
revised International Association for the Study of Pain definition of pain: 
concepts, challenges, and compromises. Pain. 2020 Sep;161(9):1976–82.  
2.  Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz 
NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT 
recommendations. Pain. 2005;  
3.  Giordano J, Abramson K, Boswell MV. Pain assessment: subjectivity, 
objectivity, and the use of neurotechnology. Pain Physician. 2010 
Aug;13(4):305–15.  
4.  Williamson A, Hoggart B. Pain: a review of three commonly used pain 
rating scales. J Clin Nurs. 2005 Aug;14(7):798–804.  
5.  Smith SM, Amtmann D, Askew RL, Gewandter JS, Hunsinger M, Jensen 
MP, et al. Pain intensity rating training: results from an exploratory study of 
the ACTTION PROTECCT system. PAIN. 2016 May;157(5):1056–64.  
6.  IASP. IASP Terminology [Internet]. https://www.iasp-pain.org/. 2017 [cited 
2019 Feb 26]. Available from: https://www.iasp-
pain.org/terminology?navItemNumber=576 
7.  IASP Task Force on Taxonomy, edited by H. Merskey and N. Bogduk. Part 
III: Pain Terms, A Current List with Definitions and Notes on Usage" (pp 
209-214) Classification of Chronic Pain [Internet]. Second. Seattle: IASP 
Press; 1994 [cited 2019 Jul 10]. Available from: https://www.iasp-
pain.org/Education/Content.aspx?ItemNumber=1698&navItemNumber=576
#Pain 
8.  Waterman C, Victor TW, Jensen MP, Gould EM, Gammaitoni AR, Galer 
BS. The Assessment of Pain Quality: An Item Response Theory Analysis. J 
Pain. 2010;  
9.  Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et 
al. Interpreting the Clinical Importance of Treatment Outcomes in Chronic 
Pain Clinical Trials: IMMPACT Recommendations. 2008.  
10.  Fillingim RB, Loeser JD, Baron R, Edwards RR. Assessment of Chronic 
Pain: Domains, Methods, and Mechanisms. J Pain. 2016;17(9):T10–T20.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
74 
11.  Schilder A, Magerl W, Klein T, Treede R-D. Assessment of pain quality 
reveals distinct differences between nociceptive innervation of low back 




12.  Vilela-Filho O, Cavalcante RBF, Moura MU, Morais BA, Dalle CR, Grandi 
FT. Pathophysiology of the constant burning, tingling element of 
neuropathic pain: A new hypothesis. Med Hypotheses. 2014;83(4):441–449.  
13.  Melzack R. The McGill Pain Questionnaire. 1983. 41–47 p.  
14.  Melzack R. The short-form McGill Pain Questionnaire. Pain. 
1987;30(2):191–7.  
15.  Hasvik E, Haugen AJ, Gjerstad J, Grøvle L. Assessing neuropathic pain in 
patients with low back-related leg pain: Comparing the painDETECT 
Questionnaire with the 2016 NeuPSIG grading system. Eur J Pain U K. 
2018;22(6):1160–1169.  
16.  Freynhagen R, Baron R, Gockel U, Tölle TR. pain 
\textlessi\textgreaterDETECT\textless/i\textgreater : a new screening 
questionnaire to identify neuropathic components in patients with back pain. 
Curr Med Res Opin. 2006;  
17.  Landmark T, Dale O, Romundstad P, Woodhouse A, Kaasa S, Borchgrevink 
PC. Development and course of chronic pain over 4 years in the general 
population: The HUNT pain study. Eur J Pain Lond Engl. 2018;22(9):1606–
16.  
18.  Cruder C, Falla D, Mangili F, Azzimonti L, Araújo LS, Williamon A, et al. 
Profiling the Location and Extent of Musicians’ Pain Using Digital Pain 
Drawings. Pain Pract. 2018;  
19.  Shaballout N, Aloumar A, Neubert T-A, Dusch M, Beissner F. Digital Pain 
Drawings Can Improve Doctors’ Understanding of Acute Pain Patients: 
Survey and Pain Drawing Analysis. JMIR MHealth UHealth. 2019 Jan 
10;7(1):e11412.  
20.  Boudreau SA, Royo AC, Matthews M, Graven-Nielsen T, Kamavuako EN, 
Slabaugh G, et al. Distinct patterns of variation in the distribution of knee 
pain. Sci Rep. 2018;8(1):16522.  
 
75 
21.  McAnany SJ. Observed Patterns of Cervical Radiculopathy: How Often Do 
They Differ from a Standard, “Netter-Diagram” Distribution? Spine J. 2017 
Oct;17(10):S207–8.  
22.  Van Boxem K, Van Zundert J, Van Zundert J, Patijn J, van Kleef M. 
Pseudoradicular and radicular low-back pain: How to diagnose clinically? 
Vol. 135. 2008. 311–312 p.  
23.  O’Neill CW, Kurgansky ME, Derby R, Ryan DP. Disc Stimulation and 
Patterns of Referred Pain: Spine. 2002 Dec;27(24):2776–81.  
24.  Bertilson BC, Brosjö E, Billing H, Strender L-E. Assessment of nerve 
involvement in the lumbar spine: agreement between magnetic resonance 
imaging, physical examination and pain drawing findings. BMC 
Musculoskelet Disord. 2010 Sep 10;11:202.  
25.  Bernhoff G, Landén Ludvigsson M, Peterson G, Bertilson BC, Elf M, 
Peolsson A. The pain drawing as an instrument for identifying cervical spine 
nerve involvement in chronic whiplash-associated disorders. J Pain Res. 
2016 Jun;397.  
26.  Ohnmeiss DD, Vanharanta H, Ekholm J. Relationship of pain drawings to 
invasive tests assessing intervertebral disc pathology. Eur Spine J Off Publ 
Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc. 
1999;8(2):126–31.  
27.  Baron R, Binder A, Wasner G. Neuropathic pain: Diagnosis, 
pathophysiological mechanisms, and treatment. Vol. 9. 2010. 807–819 p.  
28.  Baron R, Binder A, Attal N, Casale R, Dickenson AH, Treede R-D. 
Neuropathic low back pain in clinical practice. Eur J Pain Lond Engl. 
2016;20(6):861–73.  
29.  Bertilson B, Grunnesjö M, Johansson S-E, Strender L-E. Pain Drawing in 
the Assessment of Neurogenic Pain and Dysfunction in the Neck/Shoulder 
Region: Inter-Examiner Reliability and Concordance with Clinical 
Examination. Pain Med. 2007 Mar;8(2):134–46.  
30.  Downs MB, Laporte C. Conflicting Dermatome Maps: Educational and 
Clinical Implications. J Orthop Sports Phys Ther. 2011 Jun;41(6):427–34.  
31.  Dwyer A, Aprill C, Bogduk N. Cervical zygapophyseal joint pain patterns. I: 
A study in normal volunteers. Spine. 1990 Jun;15(6):453–7.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
76 
32.  Aprill C, Dwyer A, Bogduk N. Cervical zygapophyseal joint pain patterns. 
II: A clinical evaluation. Spine. 1990 Jun;15(6):458–61.  
33.  Simons DG, Travell JG, Simons LS, Travell JG. Travell & Simons’ 
myofascial pain and dysfunction: the trigger point manual. 2nd ed. 
Baltimore: Williams & Wilkins; 1999. 1 p.  
34.  Jung J-H, Kim H-I, Shin D-A, Shin D-G, Lee J-O, Kim H-J, et al. 
Usefulness of Pain Distribution Pattern Assessment in Decision-Making for 
the Patients with Lumbar Zygapophyseal and Sacroiliac Joint Arthropathy. J 
Korean Med Sci. 2007;22(6):1048.  
35.  Lesher JM, Dreyfuss P, Hager N, Kaplan M, Furman M. Hip Joint Pain 
Referral Patterns: A Descriptive Study. Pain Med. 2008 Jan;9(1):22–5.  
36.  Drew MK, Palsson TS, Hirata RP, Izumi M, Lovell G, Welvaert M, et al. 
Experimental pain in the groin may refer into the lower abdomen: 
Implications to clinical assessments. J Sci Med Sport. 2017 Oct;20(10):904–
9.  
37.  Vasseljen O, Woodhouse A, Bjørngaard JH akon, Leivseth L. Natural course 
of acute neck and low back pain in the general population: The HUNT study. 
Pain. 2013;  
38.  Grotle M, Brox JI, Veierød MB, Glomsrød B, Lønn JH, Vøllestad NK. 
Clinical course and prognostic factors in acute low back pain: Patients 
consulting primary care for the first time. Spine. 2005;  
39.  Artus M, Van Der Windt D, Jordan KP, Croft PR. The clinical course of low 
back pain: A meta-analysis comparing outcomes in randomised clinical trials 
(RCTs) and observational studies. BMC Musculoskelet Disord. 2014;  
40.  Macedo LG, Maher CG, Latimer J, McAuley JH, Hodges PW, Rogers WT. 
Nature and Determinants of the Course of Chronic Low Back Pain Over a 
12-Month Period: A Cluster Analysis. Phys Ther. 2014 Feb 1;94(2):210–21.  
41.  Enthoven P, Skargren E, Öberg B. Clinical Course in Patients Seeking 
Primary Care for Back or Neck Pain: A Prospective 5-Year Follow-Up of 
Outcome and Health Care Consumption with Subgroup Analysis: Spine. 
2004 Nov;29(21):2458–65.  
42.  Tesarz J, Gerhardt A, Hartmann M, Kohlmann T, Eich W. The Course of the 
Spatial Extent of Pain in Nonspecific Chronic Back Pain. Clin J Pain. 2016;  
 
77 
43.  Grunnesjö M, Bogefeldt J, Blomberg S, Delaney H, Svärdsudd K. The 
course of pain drawings during a 10-week treatment period in patients with 
acute and sub-acute low back pain. BMC Musculoskelet Disord. 2006;7:1–9.  
44.  Palmer H. Pain charts; a description of a technique whereby functional pain 
may be diagnosed from organic pain. N Z Med J. 1949;  
45.  Udén A, Landin LA. Pain drawing and myelography in sciatic pain. Clin 
Orthop. 1987 Mar;(216):124–30.  
46.  Shaballout N, Neubert T-A, Boudreau S, Beissner F. From Paper to Digital 
Applications of the Pain Drawing: Systematic Review of Methodological 
Milestones. JMIR MHealth UHealth. 2019 Sep 5;7(9):e14569.  
47.  Mooney V, Cairns D, Robertson J. A system for evaluating and treating 
chronic back disability. West J Med. 1976 May;124(5):370–6.  
48.  Toomey TC, Gover VF, Jones BN. Spatial distribution of pain: a descriptive 
characteristic of chronic pain. Pain. 1983 Nov;17(3):289–300.  
49.  Margolis RB, Tait RC, Krause SJ. A rating system for use with patient pain 
drawings. Pain. 1986 Jan;24(1):57–65.  
50.  Escalante A, Lichtenstein MJ, White K, Rios N, Hazuda HP. A method for 
scoring the pain map of the McGill Pain Questionnaire for use in 
epidemiologic studies. Aging Milan Italy. 1995 Oct;7(5):358–66.  
51.  Masferrer R, Prendergast V, Hagell P. Colored pain drawings: preliminary 
observations in a neurosurgical practice. Eur J Pain Lond Engl. 
2003;7(3):213–7.  
52.  Toomingas A. Characteristics of pain drawings in the neck-shoulder region 
among the working population. Int Arch Occup Environ Health. 1999 
Mar;72(2):98–106.  
53.  Wallace MS, North J, Grigsby EJ, Kapural L, Sanapati MR, Smith SG, et al. 
An Integrated Quantitative Index for Measuring Chronic Multisite Pain: The 
Multiple Areas of Pain (MAP) Study. Pain Med. 2018 Jul 1;19(7):1425–35.  
54.  Ransford A. O., Cairns D., Mooney V. The Pain Drawing as an Aid to the 
Psychologic Evaluation oi Patients With Low-Back Pain. Spine. 1(2):127–
34.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
78 
55.  Parker H, Wood PL, Main CJ. The use of the pain drawing as a screening 
measure to predict psychological distress in chronic low back pain. Spine. 
1995 Jan 15;20(2):236–43.  
56.  Udén A, Aström M, Bergenudd H. Pain drawings in chronic back pain. 
Spine. 1988 Apr;13(4):389–92.  
57.  Von Baeyer CL, Bergstrom KJ, Brodwin MG, Brodwin SK. Invalid use of 
pain drawings in psychological screening of back pain patients. Pain. 1983 
May;16(1):103–7.  
58.  Hildebrandt J, Franz CE, Choroba-Mehnen B, Temme M. The use of pain 
drawings in screening for psychological involvement in complaints of low-
back pain. Spine. 1988 Jun;13(6):681–5.  
59.  Main CJ, Wood PL, Hollis S, Spanswick CC, Waddell G. The Distress and 
Risk Assessment Method. A simple patient classification to identify distress 
and evaluate the risk of poor outcome. Spine. 1992 Jan;17(1):42–52.  
60.  Tait RC, Chibnall JT, Margolis RB. Pain extent: relations with psychological 
state, pain severity, pain history, and disability: Pain. 1990 Jun;41(3):295–
301.  
61.  Boudreau SA, Badsberg S, Christensen SW, Egsgaard LL. Digital pain 
drawings: Assessing touch-screen technology and 3D body schemas. Clin J 
Pain. 2016;  
62.  Ghinea G, Spyridonis F, Serif T, Frank AO. 3-D Pain Drawings–-Mobile 
Data Collection Using a PDA". IEEE Trans Inf Technol Biomed. 2008 
Jan;12(1):27–33.  
63.  Jaatun EAA, Haugen DF, Dahl Y, Kofod-Petersen A. Proceed with Caution: 
Transition from Paper to Computerized Pain Body Maps. Procedia Comput 
Sci. 2013;21:398–406.  
64.  Jamison RN, Washington TA, Gulur P, Fanciullo GJ, Arscott JR, McHugo 
GJ, et al. Reliability of a preliminary 3-D pain mapping program. Pain Med 
Malden Mass. 2011 Mar;12(3):344–51.  
65.  Wenngren A, Stålnacke B-M. Computerized assessment of pain drawing 
area: A pilot study. Neuropsychiatr Dis Treat. 2009;5:451–6.  
 
79 
66.  Mann NH, Brown MD, Enger I. Statistical diagnosis of lumbar spine 
disorders using computerized patient pain drawings. Comput Biol Med. 
1991;21(6):383–97.  
67.  Sanders NW, Mann NH. Automated scoring of patient pain drawings using 
artificial neural networks: efforts toward a low back pain triage application. 
Comput Biol Med. 2000 Sep;30(5):287–98.  
68.  Mann NH, Brown MD, Enger I. Expert performance in low-back disorder 
recognition using patient pain drawings. J Spinal Disord. 1992 
Sep;5(3):254–9.  
69.  North RB, Nigrin DJ, Fowler KR, Szymanski RE, Piantadosi S. Automated 
“pain drawing” analysis by computer-controlled, patient-interactive 
neurological stimulation system. Pain. 1992 Jul;50(1):51–7.  
70.  Caseiro M, Woznowski-Vu A, De Oliveira AS, Reis FJJ, Wideman TH. 
From Paper to Digitalized Body Map: A Reliability Study of the Pain Area. 
Pain Pract Off J World Inst Pain. 2019 Jul;19(6):602–8.  
71.  Jaatun E.A.A., Haugen D.F., Dahl Y., Kofod-Petersen A. Designing a 
reliable pain drawing tool: avoiding interaction flaws by better tailoring to 
patients’ impairments. Pers Ubiquitous Comput. 2015 Jul;19(3–4):635–48.  
72.  Boudreau SA, Spence R, Vasov G, Egsgaard LL. Feature extraction APP for 
pain profiles. Biosyst Biorobotics. 2014;7:853–854.  
73.  Bryner P. Extent measurement in localised low-back pain: a comparison of 
four methods. Pain. 1994 Nov;59(2):281–5.  
74.  Egsgaard LL, Christensen TS, Petersen IM, Brønnum DS, Boudreau SA. Do 
Gender-Specific and High-Resolution Three Dimensional Body Charts 
Facilitate the Communication of Pain for Women? A Quantitative and 
Qualitative Study. JMIR Hum Factors. 2016 Jul 20;3(2):e19.  
75.  Barbero M, Moresi F, Leoni D, Gatti R, Egloff M, Falla D. Test-retest 
reliability of pain extent and pain location using a novel method for pain 
drawing analysis. Eur J Pain Lond Engl. 2015 Sep;19(8):1129–38.  
76.  Boudreau SA, Kamavuako EN, Rathleff MS. Distribution and symmetrical 
patellofemoral pain patterns as revealed by high-resolution 3D body 
mapping: A cross-sectional study. BMC Musculoskelet Disord. 2017;18(1).  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
80 
77.  Galve Villa M, D Mørch C, S Palsson T, Boudreau SA. Modifiable motion 
graphics for capturing sensations. PloS One. 2020;15(2):e0229139.  
78.  Easton RM, Bendinelli C, Sisak K, Enninghorst N, Regan D, Evans J, et al. 
Recalled pain scores are not reliable after acute trauma. Injury. 2012;  
79.  Jensen MP, Mardekian J, Lakshminarayanan M, Boye ME. Validity of 24-h 
recall ratings of pain severity: Biasing effects of “Peak” and “End” pain. 
Pain. 2008;  
80.  Nordin M, Randhawa K, Torres P, Yu H, Haldeman S, Brady O, et al. The 
Global Spine Care Initiative: a systematic review for the assessment of 
spine-related complaints in populations with limited resources and in low- 
and middle-income communities. 2018.  
81.  Van den Bergh O, Walentynowicz M. Accuracy and bias in retrospective 
symptom reporting: Curr Opin Psychiatry. 2016 Sep;29(5):302–8.  
82.  Noel M, Rabbitts JA, Tai GG, Palermo TM. Remembering pain after 
surgery: A longitudinal examination of the role of pain catastrophizing in 
children’s and parents’ recall. Pain. 2015;  
83.  Stone AA, Schwartz JE, Broderick JE, Shiffman SS. Variability of 
momentary pain predicts recall of weekly pain: A consequence of the peak 
(or salience) memory heuristic. 2005.  
84.  Chen E, Zeltzer LK, Craske MG, Katz ER. Children’s memories for painful 
cancer treatment procedures: Implications for distress. Child Dev. 2000;  
85.  Gedney JJ, Logan H. Memory for stress-associated acute pain. J Pain. 2004;  
86.  Lefebvre JC, Keefe FJ. Memory for pain: The relationship of pain 
catastrophizing to the recall of daily rheumatoid arthritis pain. Clin J Pain. 
2002;  
87.  Pallegama RW, Ariyasinghe S, Perera ED, Treede RD. Influence of 
Catastrophizing and Personality Traits on Recalled Ratings of Acute Pain 
Experience in Healthy Young Adults. Pain Med Malden Mass. 2017;  
88.  Ono M, Schneider S, Junghaenel DU, Stone AA. What Affects the 
Completion of Ecological Momentary Assessments in Chronic Pain 
Research? An Individual Patient Data Meta-Analysis. J Med Internet Res. 
2019 Feb 5;21(2):e11398.  
 
81 
89.  Shiffman S, Stone AA, Hufford MR. Ecological Momentary Assessment. 
Annu Rev Clin Psychol. 2008 Apr;4(1):1–32.  
90.  May M, Junghaenel DU, Ono M, Stone AA, Schneider S. Ecological 
Momentary Assessment Methodology in Chronic Pain Research: A 
Systematic Review. J Pain. 2018 Jul;19(7):699–716.  
91.  Meister S, Deiters W, Becker S. Digital health and digital biomarkers – 
enabling value chains on health data. Curr Dir Biomed Eng [Internet]. 2016 
Jan 1 [cited 2020 Feb 26];2(1). Available from: 
https://www.degruyter.com/view/j/cdbme.2016.2.issue-1/cdbme-2016-
0128/cdbme-2016-0128.xml 
92.  Coravos A, Khozin S, Mandl KD. Developing and adopting safe and 
effective digital biomarkers to improve patient outcomes. Npj Digit Med. 
2019 Dec;2(1):14.  
93.  Graven-Nielsen T, Arendt-Nielsen L, Svensson P, Jensen TS. Experimental 
Muscle Pain: A Quantitative Study of Local and Referred Pain in Humans 
Following Injection of Hypertonic Saline. J Musculoskelet Pain. 1997;  
94.  Graven-Nielsen T, Arendt-Nielsen L, Svensson P, Jensen TS. Quantification 
of local and referred muscle pain in humans after sequential i.m. injections 
of hypertonic saline. Pain. 1997 Jan;69(1–2):111–7.  
95.  Palsson TS, Boudreau SA, Krebs HJ, Graven-Nielsen T. Experimental 
Referred Pain Extends Toward Previously Injured Location: An Explorative 
Study. J Pain. 2018 Oct;19(10):1189–200.  
96.  Andersen HH, Lo Vecchio S, Gazerani P, Arendt-Nielsen L. Dose-response 
study of topical allyl isothiocyanate (mustard oil) as a human surrogate 
model of pain, hyperalgesia, and neurogenic inflammation. Pain. 2017 
Sep;158(9):1723–32.  
97.  Gazerani P, Andersen OK, Arendt-Nielsen L. Site-specific, dose-dependent, 
and sex-related responses to the experimental pain model induced by 
intradermal injection of capsaicin to the foreheads and forearms of healthy 
humans. J Orofac Pain. 2007;21(4):289–302.  
98.  Sørensen LB, Boudreau SA, Gazerani P, Graven-Nielsen T. Enlarged Areas 
of Pain and Pressure Hypersensitivityby Spatially Distributed Intramuscular 
Injections ofLow-Dose Nerve Growth Factor. J Pain Off J Am Pain Soc. 
2019 May;20(5):566–76.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
82 
99.  Staahl C, Drewes AM. Experimental Human Pain Models: A Review of 
Standardised Methods for Preclinical Testing of Analgesics. Pharmacol 
Toxicol. 2004 Sep;95(3):97–111.  
100.  Graven-Nielsen T, Arendt-Nielsen L, Svensson P, Jensen TS. Stimulus-
response functions in areas with experimentally induced referred muscle 
pain--a psychophysical study. Brain Res. 1997 Jan 2;744(1):121–8.  
101.  Graven-Nielsen T, McArdle A, Phoenix J, Arendt-Nielsen L, Jensen TS, 
Jackson MJ, et al. In vivo model of muscle pain: quantification of 
intramuscular chemical, electrical, and pressure changes associated with 
saline-induced muscle pain in humans. Pain. 1997 Jan;69(1–2):137–43.  
102.  Mouraux A, Iannetti GD, Plaghki L. Low intensity intra-epidermal electrical 
stimulation can activate Aδ-nociceptors selectively. Pain. 2010;150(1):199–
207.  
103.  Slopsema JP, Boss JM, Heyboer LA, Tobias CM, Draggoo BP, Finn KE, et 
al. Natural Sensations Evoked in Distal Extremities Using Surface Electrical 
Stimulation. Open Biomed Eng J. 2018;  
104.  Vallbo \AA B. Sensations evoked from the glabrous skin of the human hand 
by electrical stimulation of unitary mechanosensitive afferents. Brain Res. 
1981;215(1–2):359–363.  
105.  Kellgren JH. A PRELIMINARY ACCOUNT OF REFERRED PAINS 
ARISING FROM MUSCLE. Br Med J. 1938;1(4035):1029.  
106.  Janal MN. Concerning the homology of painful experiences and pain 
descriptors: A multidimensional scaling analysis. Pain. 1996;64(2):373–378.  
107.  Janal MN, Clark WC, Carroll JD. Multidimensional scaling of painful and 
innocuous electrocutaneous stimuli: Reliability and individual differences. 
Percept Psychophys. 1991;50(2):108–116.  
108.  Steenbergen P, Buitenweg JR, Trojan J, van der Heide EM, van den Heuvel 
T, Flor H, et al. A system for inducing concurrent tactile and nociceptive 
sensations at the same site using electrocutaneous stimulation. Behav Res 
Methods. 2012;44(4):924–933.  
109.  Clark WC, Carroll JD, Janal MN. A novel method for the construction of 
verbal rating scales at the ratio scale level of measurement precision: The 
multidimensional-psychophysical scaling procedure (M-PSP). Atten Percept 
Psychophys. 2010 Feb;72(2):548–53.  
 
83 
110.  Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, et 
al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and 
Visual Analogue Scales for assessment of pain intensity in adults: a 
systematic literature review. J Pain Symptom Manage. 2011 
Jun;41(6):1073–93.  
111.  Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: 
Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain 
(NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain 
Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 
Bodily Pain Scale (SF. Arthritis Care Res. 2011;63(SUPPL. 11).  
112.  Boonstra AM, Stewart RE, Köke AJA, Oosterwijk RFA, Swaan JL, Schreurs 
KMG, et al. Cut-Off Points for Mild, Moderate, and Severe Pain on the 
Numeric Rating Scale for Pain in Patients with Chronic Musculoskeletal 
Pain: Variability and Influence of Sex and Catastrophizing. Front Psychol 
[Internet]. 2016 Sep 30 [cited 2020 Apr 22];7. Available from: 
http://journal.frontiersin.org/Article/10.3389/fpsyg.2016.01466/abstract 
113.  Tsze DS, Hirschfeld G, Dayan PS, Bulloch B, von Baeyer CL. Defining No 
Pain, Mild, Moderate, and Severe Pain Based on the Faces Pain Scale–
Revised and Color Analog Scale in Children With Acute Pain: Pediatr 
Emerg Care. 2018 Aug;34(8):537–44.  
114.  Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno 
MR, et al. Validation of Digital Visual Analog Scale Pain Scoring With a 
Traditional Paper-based Visual Analog Scale in Adults. J Am Acad Orthop 
Surg Glob Res Rev. 2018 Mar;2(3):e088.  
115.  Escalona-Marfil C, Coda A, Ruiz-Moreno J, Riu-Gispert LM, Gironès X. 
Validation of an Electronic Visual Analog Scale mHealth Tool for Acute 
Pain Assessment: Prospective Cross-Sectional Study. J Med Internet Res. 
2020 Feb 12;22(2):e13468.  
116.  Bird M-L, Callisaya ML, Cannell J, Gibbons T, Smith ST, Ahuja KD. 
Accuracy, Validity, and Reliability of an Electronic Visual Analog Scale for 
Pain on a Touch Screen Tablet in Healthy Older Adults: A Clinical Trial. 
Interact J Med Res. 2016 Jan 14;5(1):e3.  
117.  Doménech-García V, Skuli Palsson T, Boudreau SA, Herrero P, Graven-
Nielsen T. Pressure-induced referred pain areas are more expansive in 
individuals with a recovered fracture. Pain. 2018 Oct;159(10):1972–9.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
84 
118.  Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: 
Development and validation. Psychol Assess. 1995;7(4):524–32.  
119.  Michaell JL Sullivan. The Pain Catasthophizing Scale. User Manual 
[Internet]. [cited 2019 Mar 7]. Available from: https://sullivan-
painresearch.mcgill.ca/pdf/pcs/PCSManual_English.pdf 
120.  Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. 
J Health Soc Behav. 1983;24:386–96.  
121.  Wolf OT, Atsak P, de Quervain DJ, Roozendaal B, Wingenfeld K. Stress 
and Memory: A Selective Review on Recent Developments in the 
Understanding of Stress Hormone Effects on Memory and Their Clinical 
Relevance. Journal of Neuroendocrinology. 2016.  
122.  Wolf OT. The influence of stress hormones on emotional memory: 
Relevance for psychopathology. Acta Psychol (Amst). 2008;  
123.  Shields GS, Doty D, Shields RH, Gower G, Slavich GM, Yonelinas AP. 
Recent life stress exposure is associated with poorer long-term memory, 
working memory, and self-reported memory. Stress. 2017;  
124.  Kim JJ, Song EY, Kosten TA. Stress effects in the hippocampus: Synaptic 
plasticity and memory. Stress. 2006.  
125.  Schwabe L, Joëls M, Roozendaal B, Wolf OT, Oitzl MS. Stress effects on 
memory: An update and integration. Neuroscience and Biobehavioral 
Reviews. 2012.  
126.  Schwabe L, Wolf OT, Oitzl MS. Memory formation under stress: Quantity 
and quality. Neuroscience and Biobehavioral Reviews. 2010.  
127.  Lluch Girbes E, Duenas L, Barbero M, Falla D, Baert IAC, Meeus M, et al. 
Expanded Distribution of Pain as a Sign of Central Sensitization in 
Individuals With Symptomatic Knee Osteoarthritis. Phys Ther. 2016;  
128.  Bierke S, Petersen W. Influence of anxiety and pain catastrophizing on the 
course of pain within the first year after uncomplicated total knee 
replacement: a prospective study. Arch Orthop Trauma Surg. 2017;  
129.  Dave AJ, Selzer F, Losina E, Klara KM, Collins JE, Usiskin I, et al. Is there 
an association between whole-body pain with osteoarthritis-related knee 




130.  Bortsov AV, Platts-Mills TF, Peak DA, Jones JS, Swor RA, Domeier RM, et 
al. Pain distribution and predictors of widespread pain in the immediate 
aftermath of motor vehicle collision. Eur J Pain Lond Engl. 2013 
Sep;17(8):1243–51.  
131.  Ris I, Barbero M, Falla D, Larsen MH, Kraft MN, Søgaard K, et al. Pain 
extent is more strongly associated with disability, psychological factors, and 
neck muscle function in people with non-traumatic versus traumatic chronic 
neck pain: a cross sectional study. Eur J Phys Rehabil Med. 2019 
Feb;55(1):71–8.  
132.  Prins MR, van der Wurff P, Groen GJ. Chronic low back pain patients with 
accompanying leg pain: the relationship between pain extent and pain 
intensity, disability and health status. J Back Musculoskelet Rehabil. 
2013;26(1):55–61.  
133.  Ohnmeiss DD, Vanharanta H, Estlander AM, Jämsén A. The relationship of 
disability (Oswestry) and pain drawings to functional testing. Eur Spine J 
Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res 
Soc. 2000 Jun;9(3):208–12.  
134.  Reis F, Guimarães F, Nogueira LC, Meziat-Filho N, Sanchez TA, Wideman 
T. Association between pain drawing and psychological factors in 
musculoskeletal chronic pain: A systematic review. Physiother Theory Pract. 
2019 Jun;35(6):533–42.  
135.  Marshall PWM, Schabrun S, Knox MF. Physical activity and the mediating 
effect of fear, depression, anxiety, and catastrophizing on pain related 
disability in people with chronic low back pain. PloS One. 
2017;12(7):e0180788.  
136.  Willett MJ, Siebertz M, Petzke F, Erlenwein J, Rushton A, Soldini E, et al. 
The Extent of Pain Is Associated With Signs of Central Sensitization in 
Patients With Hip Osteoarthritis. Pain Pract Off J World Inst Pain. 
2020;20(3):277–88.  
137.  Rio E, Girdwood M, Thomas J, Garofalo C, Fortington LV, Docking S. Pain 
mapping of the anterior knee: injured athletes know best. Scand J Pain. 2018 
26;18(3):409–16.  
138.  Vos CJ, Verhagen AP, Passchier J, Koes BW. Clinical Course and 
Prognostic Factors in Acute Neck Pain: An Inception Cohort Study in 
General Practice. Pain Med. 2008 Jul;9(5):572–80.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
86 
139.  Artus M, van der Windt DA, Jordan KP, Hay EM. Low back pain symptoms 
show a similar pattern of improvement following a wide range of primary 
care treatments: A systematic review of randomized clinical trials. 
Rheumatology. 2010;  
140.  Gerhardt A, Hartmann M, Blumenstiel K, Tesarz J, Eich W. The prevalence 
rate and the role of the spatial extent of pain in nonspecific chronic back 
pain--a population-based study in the south-west of Germany. Pain Med 
Malden Mass. 2014 Jul;15(7):1200–10.  
141.  Lei J, You H-J. Variation of pain and vasomotor responses evoked by 
intramuscular infusion of hypertonic saline in human subjects: influence of 
gender and its potential neural mechanisms. Brain Res Bull. 2012 Apr 
10;87(6):564–70.  
142.  Lei J, You H-J, Andersen OK, Graven-Nielsen T, Arendt-Nielsen L. 
Homotopic and heterotopic variation in skin blood flow and temperature 
following experimental muscle pain in humans. Brain Res. 2008 Sep 
26;1232:85–93.  
143.  Galve Villa M, Cid Royo A, Bjarkam CR, Skuli Palsson T, Boudreau SA. 
Remote digital pain mapping and tracking in patients with chronic pain. J 
Med Internet Res. (in press).  
144.  Barbero M, Fernández-de-Las-Peñas C, Palacios-Ceña M, Cescon C, Falla 
D. Pain extent is associated with pain intensity but not with widespread 
pressure or thermal pain sensitivity in women with fibromyalgia syndrome. 
Clin Rheumatol. 2017 Jun;36(6):1427–32.  
145.  Miró J, de la Vega R, Tomé-Pires C, Sánchez-Rodríguez E, Castarlenas E, 
Jensen MP, et al. Pain extent and function in youth with physical disabilities. 
J Pain Res. 2017;10:113–20.  
146.  Miró J, Gertz KJ, Carter GT, Jensen MP. Pain location and intensity impacts 
function in persons with myotonic dystrophy type 1 and 
facioscapulohumeral dystrophy with chronic pain. Muscle Nerve. 2014 
Jun;49(6):900–5.  
147.  Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in 
localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010 
Oct;6(10):599–606.  
148.  Martinez-Calderon J, Struyf F, Meeus M, Luque-Suarez A. The association 
between pain beliefs and pain intensity and/or disability in people with 
 
87 
shoulder pain: A systematic review. Musculoskelet Sci Pract. 2018;37:29–
57.  
149.  Millere A, Kalnberza-Ribule Z, Mezals M, Nulle A, Millere I, Deklava L. 
Disability, pain catastrophizing and stress coping of patients with low back 
pain in rehabilitation practice in Latvia. J Back Musculoskelet Rehabil. 
2020;33(2):323–8.  
150.  Wertli MM, Eugster R, Held U, Steurer J, Kofmehl R, Weiser S. 
Catastrophizing-a prognostic factor for outcome in patients with low back 
pain: a systematic review. Spine J Off J North Am Spine Soc. 2014 Nov 
1;14(11):2639–57.  
151.  Jensen MP, Johnson LE, Gertz KJ, Galer BS, Gammaitoni AR. The words 
patients use to describe chronic pain: Implications for measuring pain 
quality. Pain. 2013;  
152.  Dworkin RH, Jensen MP, Gammaitoni AR, Olaleye DO, Galer BS. 
Symptom Profiles Differ in Patients With Neuropathic Versus Non-
neuropathic Pain. J Pain. 2007 Feb;8(2):118–26.  
153.  Fernandez E, Vargas R, Mahometa M, Ramamurthy S, Boyle GJ. 
Descriptors of pain sensation: A dual hierarchical model of latent structure. J 
Pain. 2012;13(6):532–536.  
154.  Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL. 
Sex, gender, and pain: a review of recent clinical and experimental findings. 
J Pain Off J Am Pain Soc. 2009 May;10(5):447–85.  
155.  Rau C-L, Yang J-L, Lin J-J, Wu P-C, Hou C-Y, Song C-Y, et al. Pain 
quality descriptors and sex-related differences in patients with shoulder pain. 
J Pain Res. 2018;11:1803–9.  
156.  Robinson ME, Wise EA, Riley III JL, Atchison JW. Sex differences in 
clinical pain: a multisample study. J Clin Psychol Med Settings. 
1998;5(4):413–24.  
157.  MacDermid JC, Walton DM, Bobos P, Lomotan M, Carlesso L. A 
Qualitative Description of Chronic Neck Pain has Implications for Outcome 
Assessment and Classification. Open Orthop J. 2016;10:746–56.  
158.  Bennett M. The LANSS Pain Scale: The Leeds assessment of neuropathic 
symptoms and signs. Pain. 2001;  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
88 
159.  Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. 
Comparison of pain syndromes associated with nervous or somatic lesions 
and development of a new neuropathic pain diagnostic questionnaire (DN4). 
Pain. 2005;  
160.  Tölle TR, Baron R, de Bock E, Junor R, Dias Barbosa C, Marshall SF, et al. 
painPREDICT: first interim data from the development of a new patient-
reported pain questionnaire to predict treatment response using sensory 
symptom profiles. Curr Med Res Opin. 2019;35(7):1177–85.  
161.  Foley G, Timonen V. Using Grounded Theory Method to Capture and 
Analyze Health Care Experiences. Health Serv Res. 2015 Aug;50(4):1195–
210.  
162.  Stynes S, Konstantinou K, Ogollah R, Hay EM, Dunn KM. Clinical 
diagnostic model for sciatica developed in primary care patients with low 
back-related leg pain. PloS One. 2018;13(4):e0191852.  
163.  Stynes S, Konstantinou K, Dunn KM. Classification of patients with low 
back-related leg pain: a systematic review. BMC Musculoskelet Disord. 
2016 23;17:226.  
164.  Robinson JR. Lower Extremity Pain of Lumbar Spine Origin: Differentiating 
Somatic Referred and Radicular Pain. J Man Manip Ther. 2003 
Oct;11(4):223–34.  
165.  Khan RS, Ahmed K, Blakeway E, Skapinakis P, Nihoyannopoulos L, 
MacLeod K, et al. Catastrophizing: A predictive factor for postoperative 
pain. Am J Surg. 2011;  
166.  Leeuw M, Goossens MEJB, Linton SJ, Crombez G, Boersma K, Vlaeyen 
JWS. The Fear-Avoidance Model of Musculoskeletal Pain: Current State of 
Scientific Evidence. J Behav Med. 2007 Jan 31;30(1):77–94.  
167.  Koban L, Wager TD. Beyond conformity: Social influences on pain reports 
and physiology. Emotion. 2016 Feb;16(1):24–32.  
168.  Edwards RR, Dworkin RH, Sullivan MD, Turk DC, Wasan AD. The Role of 
Psychosocial Processes in the Development and Maintenance of Chronic 
Pain. J Pain. 2016 Sep;17(9):T70–92.  
169.  Eberly L, Richter D, Comerci G, Ocksrider J, Mercer D, Mlady G, et al. 
Psychosocial and demographic factors influencing pain scores of patients 
 
89 
with knee osteoarthritis. Isales CM, editor. PLOS ONE. 2018 Apr 
9;13(4):e0195075.  
170.  Kristiansen FL, Olesen AE, Brock C, Gazerani P, Petrini L, Mogil JS, et al. 
The role of pain catastrophizing in experimental pain perception. Pain Pract 
Off J World Inst Pain. 2014 Mar;14(3):E136-145.  
171.  Suso-Ribera C, Castilla D, Zaragozá I, Ribera-Canudas MV, Botella C, 
García-Palacios A. Validity, Reliability, Feasibility, and Usefulness of Pain 
Monitor, a Multidimensional Smartphone App for Daily Monitoring of 
Adults with Heterogeneous Chronic Pain: Clin J Pain. 2018 Apr;1.  
172.  Aaron LA, Mancl L, Turner JA, Sawchuk CN, Klein KM. Reasons for 
missing interviews in the daily electronic assessment of pain, mood, and 
stress: Pain. 2004 Jun;109(3):389–98.  
173.  Stone AA, Shiffman S. Capturing momentary, self-report data: a proposal 
for reporting guidelines. Ann Behav Med Publ Soc Behav Med. 
2002;24(3):236–43.  
174.  Holthe T, Halvorsrud L, Karterud D, Hoel K-A, Lund A. Usability and 
acceptability of technology for community-dwelling older adults with mild 
cognitive impairment and dementia: a systematic literature review. Clin 
Interv Aging. 2018;13:863–86.  
175.  Merchant R, Inamdar R, Henderson K, Barrett M, Su JG, Riley J, et al. 
Digital Health Intervention for Asthma: Patient-Reported Value and 
Usability. JMIR MHealth UHealth. 2018 Jun 4;6(6):e133.  
176.  Shaw J, Agarwal P, Desveaux L, Palma DC, Stamenova V, Jamieson T, et 
al. Beyond “implementation”: digital health innovation and service design. 
Npj Digit Med. 2018 Dec;1(1):48.  
177.  Steele Gray C. Seeking Meaningful Innovation: Lessons Learned 
Developing, Evaluating, and Implementing the Electronic Patient-Reported 
Outcome Tool. J Med Internet Res. 2020 Jul 29;22(7):e17987.  
178.  Morren M, van Dulmen S, Ouwerkerk J, Bensing J. Compliance with 
momentary pain measurement using electronic diaries: a systematic review. 
Eur J Pain Lond Engl. 2009 Apr;13(4):354–65.  
179.  Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically 
important changes in chronic musculoskeletal pain intensity measured on a 
numerical rating scale. Eur J Pain Lond Engl. 2004 Aug;8(4):283–91.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
90 
180.  Egloff N, Cámara RJA, von Känel R, Klingler N, Marti E, Ferrari M-LG. 
Pain drawings in somatoform-functional pain. BMC Musculoskelet Disord. 
2012 Dec 20;13:257.  
181.  Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DLH, 
Bouhassira D, et al. Neuropathic pain: an updated grading system for 
research and clinical practice. PAIN. 2016 Aug;157(8):1599–606.  
182.  Verhagen AP, Downie A, Popal N, Maher C, Koes BW. Red flags presented 
in current low back pain guidelines: a review. Eur Spine J. 2016 
Sep;25(9):2788–802.  
183.  Lee SL, Ho HS. Acute Appendicitis: Is There a Difference between Children 
and Adults? Am Surg. 2006 May;72(5):409–13.  
184.  Kwon O-K. Headache and Aneurysm. Neuroimaging Clin N Am. 2019 
May;29(2):255–60.  
185.  Mansfield KE, Sim J, Jordan JL, Jordan KP. A systematic review and meta-
analysis of the prevalence of chronic widespread pain in the general 
population. Pain. 2016 Jan;157(1):55–64.  
186.  Andrews P, Steultjens M, Riskowski J. Chronic widespread pain prevalence 
in the general population: A systematic review. Eur J Pain. 2018 
Jan;22(1):5–18.  
187.  Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS. 
Do Pain Qualities and Spatial Characteristics Make Independent 
Contributions to Interference With Physical and Emotional Functioning? J 
Pain. 2006;  
188.  Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner 
S, et al. Development and initial validation of an expanded and revised 
version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 
2009;144(1–2):35–42.  
189.  Schmid AB, Tampin B. Chapter 10, section 10. Spinally referred back and 
leg pain. In: Lumbar Spine Online Textbook [Internet]. International Society 





190.  Victor TW, Jensen MP, Gammaitoni AR, Gould EM, White RE, Galer BS. 
The Dimensions of Pain Quality: Factor Analysis of the Pain Quality 
Assessment Scale. Clin J Pain. 2008;  
191.  Fernandez E, Krusz JC, Hall S. Parsimonious collection of pain descriptors: 
Classification and calibration by pain patients. J Pain. 2011;12(4):444–450.  
192.  Wilson Dianne; Williams Marie; Butler David. Language and the pain 
experience. Physiother Res Int. 2008;4(1):56–65.  
193.  Lalloo C, Kumbhare D, Stinson JN, Henry JL. Pain-QuILT: Clinical 
feasibility of a web-based visual pain assessment tool in adults with chronic 
pain. J Med Internet Res. 2014;  
194.  Jonassaint C, Rao N, Sciuto A, Switzer G, De Castro L, Kato G, et al. Using 
Abstract Animations as an Innovative Technology-Based Approach to 
Measuring Pain in Adults (Preprint). J Med Internet Res [Internet]. 2018 
Feb; Available from: http://preprints.jmir.org/preprint/10056/accepted 
195.  Lalloo C, Stinson JN, Hochman JR, Adachi JD, Henry JL. Adapting the 
Iconic Pain Assessment Tool Version 2 (IPAT2) for Adults and Adolescents 
With Arthritis Pain Through Usability Testing and Refinement of Pain 
Quality Icons: Clin J Pain. 2013 Mar;29(3):253–64.  
196.  Melzack R. The McGill Pain Questionnaire: Major properties and scoring 
methods. Pain. 1975;1(3):277–299.  
197.  Nishigami T, Mibu A, Osumi M, Son K, Yamamoto S, Kajiwara S, et al. Are 
tactile acuity and clinical symptoms related to differences in perceived body 
image in patients with chronic nonspecific lower back pain? Man Ther. 2015 
Feb;20(1):63–7.  
198.  Adamczyk WM, Luedtke K, Saulicz O, Saulicz E. Sensory dissociation in 
chronic low back pain: Two case reports. Physiother Theory Pract. 2018 
Aug;34(8):643–51.  
199.  Lee TD, Swanson LR, Hall AL. What Is Repeated in a Repetition? Effects of 
Practice Conditions on Motor Skill Acquisition. Phys Ther. 1991 Feb 
1;71(2):150–6.  
200.  Magallón S, Narbona J, Crespo-Eguílaz N. Acquisition of Motor and 
Cognitive Skills through Repetition in Typically Developing Children. Ito E, 
editor. PLOS ONE. 2016 Jul 6;11(7):e0158684.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
92 
201.  Spyridonis F, Hansen J, Grønli T-M, Ghinea G. PainDroid: an android-based 
virtual reality application for pain assessment. Multimed Tools Appl. 2014 
Sep;72(1):191–206.  
202.  Turton AJ, Palmer M, Grieve S, Moss TP, Lewis J, McCabe CS. Evaluation 
of a Prototype Tool for Communicating Body Perception Disturbances in 
Complex Regional Pain Syndrome. Front Hum Neurosci [Internet]. 2013 
[cited 2019 May 7];7. Available from: 
http://journal.frontiersin.org/article/10.3389/fnhum.2013.00517/abstract 
203.  Stone AA, Broderick JE, Schwartz JE, Shiffman S, Litcher-Kelly L, 
Calvanese P. Intensive momentary reporting of pain with an electronic diary: 
reactivity, compliance, and patient satisfaction. Pain. 2003 Jul;104(1–
2):343–51.  
204.  Vaegter HB, Fehrmann E, Gajsar H, Kreddig N. Endogenous Modulation of 
Pain: The Role of Exercise, Stress, and Cognitions in Humans. Clin J Pain. 
2020 Mar;36(3):150–61.  
205.  Daenen L, Varkey E, Kellmann M, Nijs J. Exercise, not to exercise, or how 
to exercise in patients with chronic pain? Applying science to practice. Clin 
J Pain. 2015 Feb;31(2):108–14.  
206.  Farrington DP. Longitudinal research strategies: advantages, problems, and 
prospects. J Am Acad Child Adolesc Psychiatry. 1991 May;30(3):369–74.  
207.  Palta M, Yao TJ. Analysis of longitudinal data with unmeasured 
confounders. Biometrics. 1991 Dec;47(4):1355–69.  
208.  Pierce M, Dunn G, Millar T. Confounding in longitudinal studies in 
addiction treatment research. Addict Res Theory. 2017 May 4;25(3):236–42.  
209.  Welk GJ, Bai Y, Lee J-M, Godino J, Saint-Maurice PF, Carr L. 
Standardizing Analytic Methods and Reporting in Activity Monitor 
Validation Studies: Med Sci Sports Exerc. 2019 Mar;1.  
210.  Chokshi SK, Mann DM. Innovating From Within: A Process Model for 
User-Centered Digital Development in Academic Medical Centers. JMIR 
Hum Factors. 2018 Dec 19;5(4):e11048.  
211.  Arevian AC, O’Hora J, Jones F, Mango J, Jones L, Williams PG, et al. 
Participatory Technology Development to Enhance Community Resilience. 
Ethn Dis. 2018;28(Suppl 2):493–502.  
 
93 
212.  Alonso-Betanzos A, Bolón-Canedo V. Big-Data Analysis, Cluster Analysis, 
and Machine-Learning Approaches. Adv Exp Med Biol. 2018;1065:607–26.  
213.  Nam KH, Kim DH, Choi BK, Han IH. Internet of Things, Digital 
Biomarker, and Artificial Intelligence in Spine: Current and Future 
Perspectives. Neurospine. 2019 Dec 31;16(4):705–11.  
214.  Riley P. Three pitfalls to avoid in machine learning. Nature. 2019 
Aug;572(7767):27–9.  
215.  Vogt H, Green S, Ekstrøm CT, Brodersen J. How precision medicine and 
screening with big data could increase overdiagnosis. BMJ. 2019 Sep 
13;l5270.  
216.  Margoles M. Letter to the editor. PAIN. 1980;8:115–7.  
217.  Margolis RB, Krause SJ, Tait RC. Lateralization of chronic pain. PAIN. 
1985;23:289–93.  
218.  Fordyce WE, Brockway JA, Bergman JA, Spengler D. Acute Back Pain: A 
Control-Group Comparison of Behavioral vs Traditional Management 
Methods. J Behav Med. 1986;9(2).  
219.  Gatchel RJ, Mayer TG, Capra P, Diamond P, Barnett J. Quantification of 
lumbar function. Part 6: The use of psychological measures in guiding 
physical functional restoration. Spine. 1986 Feb;11(1):36–42.  
220.  Cummings GS, Routan JL. Accuracy of the unassisted pain drawings by 
patients with chronic pain. J Orthop Sports Phys Ther. 1987;8(8):391–6.  
221.  Donelson R, Grant W, Kamps C, Medcalf R. Pain response to sagittal end-
range spinal motion. A prospective, randomized, multicentered trial. Spine. 
1991 Jun;16(6 Suppl):S206-212.  
222.  Toomey TC, Mann JD, Abashian S, Thompson-Pope S. Relationship of pain 
drawing scores to ratings of pain description and function. Clin J Pain. 1991 
Dec;7(4):269–74.  
223.  Mann NH, Brown MD. Artificial intelligence in the diagnosis of low back 
pain. Orthop Clin North Am. 1991 Apr;22(2):303–14.  
224.  Sivik TM, Gustafsson E, Olsson KK. Differential diagnosis of low-back pain 
patients: A simple quantification of the pain drawing. Nord J Psychiatry. 
1992 Jan;46(1):55–62.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
94 
225.  Bolton JE, Christensen MN. Back pain distribution patterns: relationship to 
subjective measures of pain severity and disability. J Manipulative Physiol 
Ther. 1994 May;17(4):211–8.  
226.  Escalante A, Lichtenstein MJ, Lawrence VA, Roberson M, Hazuda HP. 
Where does it hurt? Stability of recordings of pain location using the McGill 
Pain Map. J Rheumatol. 1996 Oct;23(10):1788–93.  
227.  Ohlund C, Eek C, Palmbald S, Areskoug B, Nachemson A. Quantified pain 
drawing in subacute low back pain. Validation in a nonselected outpatient 
industrial sample. Spine. 1996 May 1;21(9):1021–30; discussion 1031.  
228.  Brismar H, Vucetic N, Svensson O. Pain patterns in lumbar disc hernia 
Drawings compared to surgical findings in 159 patients. Acta Orthop Scand. 
1996 Oct;67(5):470–2.  
229.  Türp JC, Kowalski CJ, Stohler CS. Greater disability with increased pain 
involvement, pain intensity and depressive preoccupation. Eur J Pain Lond 
Engl. 1997;1(4):271–7.  
230.  Ohnmeiss DD, Vanharanta H, Ekholm J. Degree of disc disruption and 
lower extremity pain. Spine. 1997 Jul 15;22(14):1600–5.  
231.  Sturesson B, Udén G, Udén A. Pain pattern in pregnancy and “catching” of 
the leg in pregnant women with posterior pelvic pain. Spine. 1997 Aug 
15;22(16):1880–3; discussion 1884.  
232.  Roach KE, Brown MD, Dunigan KM, Kusek CL, Walas M. Test-retest 
reliability of patient reports of low back pain. J Orthop Sports Phys Ther. 
1997 Nov;26(5):253–9.  
233.  Türp JC, Kowalski CJ, O’Leary N, Stohler CS. Pain maps from facial pain 
patients indicate a broad pain geography. J Dent Res. 1998 Jun;77(6):1465–
72.  
234.  Alo KM, Yland MJ, Kramer DL, Charnov JH, Redko V. Computer assisted 
and patient interactive programming of dual octrode spinal cord stimulation 
in the treatment of chronic pain. Neuromodulation J Int Neuromodulation 
Soc. 1998 Jan;1(1):30–45.  
235.  Reigo T, Tropp H, Timpka T. Pain drawing evaluation--the problem with the 
clinically biased surgeon. Intra- and interobserver agreement in 50 cases 
related to clinical bias. Acta Orthop Scand. 1998 Aug;69(4):408–11.  
 
95 
236.  Ohnmeiss DD, Vanharanta H, Ekholm J. Relation between pain location and 
disc pathology: a study of pain drawings and CT/discography. Clin J Pain. 
1999 Sep;15(3):210–7.  
237.  Türp JC, Kowalski CJ, Stohler CS. Generic pain intensity scores are affected 
by painful comorbidity. J Orofac Pain. 2000;14(1):47–51.  
238.  Ghinea G, Gill D, Frank A, de Souza LH. Using geographical information 
systems for management of back-pain data. J Manag Med. 2002;16(2–
3):219–37.  
239.  Gagliese L, Melzack R. Age-related differences in the qualities but not the 
intensity of chronic pain. Pain. 2003 Aug;104(3):597–608.  
240.  Bertilson BC, Grunnesjö M, Strender L-E. Reliability of clinical tests in the 
assessment of patients with neck/shoulder problems-impact of history. 
Spine. 2003 Oct 1;28(19):2222–31.  
241.  North RB, Calkins S-K, Campbell DS, Sieracki JM, Piantadosi S, Daly MJ, 
et al. Automated, patient-interactive, spinal cord stimulator adjustment: a 
randomized controlled trial. Neurosurgery. 2003 Mar;52(3):572–80; 
discussion 579-580.  
242.  Jamison RN, Fanciullo GJ, Baird JC. Computerized dynamic assessment of 
pain: comparison of chronic pain patients and healthy controls. Pain Med 
Malden Mass. 2004 Jun;5(2):168–77.  
243.  Hwang M, Kang YK, Shin JY, Kim DH. Referred pain pattern of the 
abductor pollicis longus muscle. Am J Phys Med Rehabil. 2005 
Aug;84(8):593–7.  
244.  Gibson J, Frank A. Pain experienced by electric-powered chair users: a pilot 
exploration using pain drawings. Physiother Res Int. 2005 Jun;10(2):110–5.  
245.  Slipman CW, Plastaras C, Patel R, Isaac Z, Chow D, Garvan C, et al. 
Provocative cervical discography symptom mapping. Spine J. 2005 
Jul;5(4):381–8.  
246.  Cornwall J, John Harris A, Mercer SR. The lumbar multifidus muscle and 
patterns of pain. Man Ther. 2006 Feb;11(1):40–5.  
247.  Friedrich M, Gittler G, Pieler-Bruha E. Misleading history of pain location 
in 51 patients with osteoporotic vertebral fractures. Eur Spine J Off Publ Eur 
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
96 
Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc. 2006 
Dec;15(12):1797–800.  
248.  Carnes D, Parsons S, Ashby D, Breen A, Foster NE, Pincus T, et al. Chronic 
musculoskeletal pain rarely presents in a single body site: results from a UK 
population study. Rheumatol Oxf Engl. 2007 Jul;46(7):1168–70.  
249.  Linder J, Svensson O. The impact of pain and depression on assessment of 
rehabilitation need: a cross-sectional study in long-term sick-listed patients. 
Int J Rehabil Res Int Z Rehabil Rev Int Rech Readaptation. 2007 
Sep;30(3):255–60.  
250.  Thompson LR, Boudreau R, Hannon MJ, Newman AB, Chu CR, Jansen M, 
et al. The knee pain map: reliability of a method to identify knee pain 
location and pattern. Arthritis Rheum. 2009 Jun 15;61(6):725–31.  
251.  McClish DK, Smith WR, Dahman BA, Levenson JL, Roberts JD, Penberthy 
LT, et al. Pain site frequency and location in sickle cell disease: the PiSCES 
project. Pain. 2009 Sep;145(1–2):246–51.  
252.  Felix E, Galoian K, Aarons C, Brown M, Kearing S, Heiss U. Utility of 
Quantitative Computerized PainDrawings in a Sample of Spinal 
StenosisPatients. Pain Med. 2010;11:382–9.  
253.  Jud SM, Fasching PA, Maihöfner C, Heusinger K, Loehberg CR, Hatko R, 
et al. Pain perception and detailed visual pain mapping in breast cancer 
survivors. Breast Cancer Res Treat. 2010 Jan;119(1):105–10.  
254.  Persson AL, Garametsos S, Pedersen J. Computer-aided surface estimation 
of pain drawings - intra- and inter-rater reliability. J Pain Res. 2011;4:135–
41.  
255.  Elson DW, Jones S, Caplan N, Stewart S, St Clair Gibson A, Kader DF. The 
photographic knee pain map: Locating knee pain with an instrument 
developed for diagnostic, communication and research purposes. The Knee. 
2011 Dec;18(6):417–23.  
256.  Alonso-Blanco C, Fernández-de-Las-Peñas C, de-la-Llave-Rincón AI, 
Zarco-Moreno P, Galán-Del-Río F, Svensson P. Characteristics of referred 
muscle pain to the head from active trigger points in women with myofascial 




257.  Pierce H, Homer CSE, Dahlen HG, King J. Pregnancy-Related Lumbopelvic 
Pain: Listening to Australian Women. Nurs Res Pract. 2012;2012:1–10.  
258.  Renner SP, Boosz AS, Burghaus S, Maihöfner C, Beckmann MW, Fasching 
PA, et al. Visual pain mapping in endometriosis. Arch Gynecol Obstet. 2012 
Sep;286(3):687–93.  
259.  Chatterton BD, Muller S, Thomas MJ, Menz HB, Rome K, Roddy E. Inter 
and intra-rater repeatability of the scoring of foot pain drawings. J Foot 
Ankle Res. 2013 Nov 1;6(1):44.  
260.  Southerst D, Stupar M, Côté P, Mior S, Stern P. The Reliability of 
Measuring Pain Distribution and Location Using Body Pain Diagrams in 
Patients With Acute Whiplash-Associated Disorders. J Manipulative Physiol 
Ther. 2013 Sep;36(7):395–402.  
261.  Gumina S, Candela V, Passaretti D, Venditto T, Carbone S, Arceri V, et al. 
Intensity and distribution of shoulder pain in patients with different sized 
postero-superior rotator cuff tears. J Shoulder Elbow Surg. 2014 
Jun;23(6):807–13.  
262.  Tucker KJ, Fels M, Walker SR, Hodges PW. Comparison of location, depth, 
quality, and intensity of experimentally induced pain in 6 low back muscles. 
Clin J Pain. 2014 Sep;30(9):800–8.  
263.  Barmettler G, Brawn J, Maleki N, Scrivani S, Burstein R, Becerra L, et al. A 
new electronic diary tool for mapping and tracking spatial and temporal head 
pain patterns in migraine. Cephalalgia Int J Headache. 2015 Apr;35(5):417–
25.  
264.  Nickel JC, Tripp DA, International Interstitial Cystitis Study Group. Clinical 
and psychological parameters associated with pain pattern phenotypes in 
women with interstitial cystitis/bladder pain syndrome. J Urol. 2015 
Jan;193(1):138–44.  
265.  Torstensson T, Butler S, Lindgren A, Peterson M, Eriksson M, Kristiansson 
P. Referred Pain Patterns Provoked on Intra-Pelvic Structures among 
Women with and without Chronic Pelvic Pain: A Descriptive Study. Price 
TJ, editor. PLOS ONE. 2015 Mar 20;10(3):e0119542.  
266.  van Hecke O, Kamerman PR, Attal N, Baron R, Bjornsdottir G, Bennett 
DLH, et al. Neuropathic pain phenotyping by international consensus 
(NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi 
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      
USING DIGITAL HEALTH TECHNOLOGY 
98 
survey, and expert panel recommendations. Pain. 2015 Nov;156(11):2337–
53.  
267.  Van Ginckel A, Bennell KL, Campbell PK, Wrigley TV, Hunter DJ, Hinman 
RS. Location of knee pain in medial knee osteoarthritis: patterns and 
associations with self-reported clinical symptoms. Osteoarthritis Cartilage. 
2016;24(7):1135–42.  
268.  Hawkins JM, Schmidt JE, Hargitai IA, Johnson JF, Howard RS, Bertrand 
PM. Multimodal Assessment of Body Pain in Orofacial Pain Patients. Pain 
Med Malden Mass. 2016 Feb 10;  
269.  Falla D, Peolsson A, Peterson G, Ludvigsson ML, Soldini E, Schneebeli A, 
et al. Perceived pain extent is associated with disability, depression and self-
efficacy in individuals with whiplash-associated disorders. Eur J Pain Lond 
Engl. 2016;20(9):1490–501.  
270.  Poulsen E, Overgaard S, Vestergaard JT, Christensen HW, Hartvigsen J. 
Pain distribution in primary care patients with hip osteoarthritis. Fam Pract. 
2016 Dec;33(6):601–6.  
271.  Zhang, C., Kjellström, H, Ek, C. H., Bertilson, B.C. Diagnostic Prediction 
Using Discomfort Drawings with IBTM. Proc Mach Learn Healthc. 
2016;56.  
272.  Candela V, Giannicola G, Passaretti D, Venditto T, Gumina S. Adhesive 
capsulitis of the shoulder: pain intensity and distribution. Musculoskelet 
Surg. 2017 Dec;101(Suppl 2):153–8.  
273.  Rio E, Girdwood M, Thomas J, Garofalo C, Fortington LV, Docking S. Pain 
mapping of the anterior knee: injured athletes know best. Scand J Pain. 2018 
26;18(3):409–16.  
274.  Neubert T-A, Dusch M, Karst M, Beissner F. Designing a Tablet-Based 
Software App for Mapping Bodily Symptoms: Usability Evaluation and 
Reproducibility Analysis. JMIR MHealth UHealth. 2018 May 30;6(5):e127.  
275.  Wallace MS, North J, Grigsby EJ, Kapural L, Sanapati MR, Smith SG, et al. 
An Integrated Quantitative Index for Measuring Chronic Multisite Pain: The 
Multiple Areas of Pain (MAP) Study. Pain Med Malden Mass. 2018 Feb 21;  
276.  Swinnen TW, Westhovens R, Dankaerts W, de Vlam K. Widespread pain in 
axial spondyloarthritis: clinical importance and gender differences. Arthritis 
Res Ther. 2018 27;20(1):156.  
 
99 
277.  Fernández-de-Las-Peñas C, Falla D, Palacios-Ceña M, De-la-Llave-Rincón 
AI, Schneebeli A, Barbero M. Perceived Pain Extent Is Not Associated with 
Physical, Psychological, or Psychophysical Outcomes in Women with 
Carpal Tunnel Syndrome. Pain Med Malden Mass. 2019 01;20(6):1185–92.  
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      





APPENDIX. SUMMARY OF STUDIES 
USING PAIN DRAWINGS  
This table shows the evolution of pain drawings and the changes in the use and 
patient population about time. Pain drawings’ methodological milestones, as 
inspired by Shaballout (46), in the areas of concept development (*), data 
acquisition (#), data analysis (§), and visualization (¤) are highlighted in the table 
(N/A=not applicable). 
Authors Year Study population Main findings 
Palmer (44) # § 1949 Patients with pain Symmetry in the pain drawings can 
differentiate between organic and 
functional nervous disorders. 
Melzack (196) * 1975 N/A Development of the McGill Pain 
Questionnaire scoring system. 
Mooney, Cairns, 
Robertson  (47) * 
1976 Patients with prolonged 
pain disability 
Evaluation of five methods to assess 
psychological treatment. 
Ransford, Cairns, 
Mooney (54) § 
1976 Patients with low-back 
pain 
A pain drawing scoring system is 
associated with hypochondriasis and 
hysteria. 
Margoles      
(216) *# 
1980 N/A Proposition for a standardized body 
charts template with four views to cover 
all body areas. 
Toomey, Gover, 
Jones (48) # § 
1983 Patients with chronic 
facial, back, or 
extremity pain 
Spatial distribution of pain sites can be a 
useful clinical indicator of psychological 
disturbance. 
Margolis, Krause, 
Tait (217) § 
1985 Patients with chronic 
pain 
Development of a pain drawing 
lateralization scoring system based on 
the number of body areas. 
Fordyce et al.    
(218) § 
1986 Patients with acute 
low-back pain 
Patients from the behavioral treatment 
group had returned to pre-pain onset 
outcomes at the 9-12 months follow up. 
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Gatchel et al.    
(219) § 
1986 Patients with chronic 
low-back pain 
Multi-modal pain management 
improves psychological outcomes and 
physical function. 
Margolis, Tait, 
Kraus (49) § 
1986 Patients with chronic 
low-back pain 
A body surface scoring system can 
predict psychological distress or 
disfunction. 
Cummings, 
Routan (220) * § 
1987 Patients with chronic 
pain 
The area of pain is more accurately 
represented by doctors-driven pain 
drawings, than patient self-reported pain 
drawings. 
Udén, Landin      
(45) * # § 
1987 Patients with clinical 
suspicion of a 
prolapsed disc 
Pain drawings alone cannot predict the 
presence or absence of a prolapsed disc. 
Hldebrandt et al.  
(58) * § 
1988 Patients with low-back 
pain 
A pain drawing scoring system is unable 
to screen for psychological impairment. 
Donelson et al. 
(221) § 
1991 Patients with 
nonspecific low-back 
pain with or without 
referred leg pain 
The location of referred pain and the 
intensity of central and referred pain can 
be changed by spinal flexion and 
extension movements. 
Toomey et al. 
(222) 
1991 Patients with chronic 
pain 
Pain distribution may be a clinically 
relevant marker of disability in patients 
with chronic pain. 
Mann, Brown   
(223) # § ¤ 
1991 Patients with low-back 
pain 
Development of an artificial neuronal 
network to recognize patterns of pain 
description using pain drawings. 
Mann, Brown, 
Enger (66) # § 
1991 Patients with low-back 
pain 
A computerized statistical method can 
assist to classify pain drawings into 




1992 Patients with back pain The frequency scoring of pain drawing 
can be used as a screening tool for 
psychological vulnerability. 
North el at.     
(69) # § 
1992 Patients with spinal 
cord stimulator  
Computerized analysis can be useful to 
indicate the electrodes’ positioning. 
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Bryner (73) # § 1994 Patients with low-back 
pain 
Grid-based assessments of pain 




1994 Patients with low-back 
pain 
Pain distribution, but not extent, can 
assist towards subgrouping of patient 
with back pain. 




Development of a scoring system for the 
McGill Pain body chart. 
Parker, Wood, 
Main (55) § 
1995 Patients with chronic 
low-back pain 
Three pain drawing scoring systems 
cannot differentiate patients with 
psychological distress, between organic 
and non-organic pain patterns. 
Escalante et al. 
(226) 
1996 Rheumatology and 
post-surgical patients 
Validation of a scoring system for the 
McGill Pain body chart to assess pain 
distribution. 
Ohlund et al. 
(227) 
1996 Blue collar workers A body area score of pain extent may be 




1996 Patients referred to 
lumbar disc surgery 
A pain drawing scoring system is not 
supported as a pre-operative 
psychological screening tool 
Türp, Kowalski, 
Stohler (229) § 
1997 Female patients with 
chronic facial pain 
Pain intensity, pain distribution and high 
scores in the Beck depression inventory 





1997 Patients undergoing 
discography 




1997 Pregnant women Women with posterior pelvic tilt are 
more likely to have referred leg pain. 
Roach et al. (232) 1997 Patients with low-back 
pain 
Pain intensity, pain drawings and a 
position questionnaire have a good test-
retest reliability. 
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Türp et al. (233) 1998 Female patients with 
chronic facial pain 
Widespread pain is prevalent in patients 
with chronic facial pain. 
Alo et al (234) # 1998 Patients with spinal 
cord stimulator 
Multiple electrodes and stimulation 
programs can reduce pain intensity and 
increase paresthesia overlap. 
Reigo, Troop, 
Timpka (235) # 
1998 Patients with low-back 
pain 
Knowledge of the patient’s clinical 





1999 Patients with low-back 
pain with or without 
leg pain 
Pain drawings may be a co-adjuvant 
diagnostic tool to identify the disc level 
associated with the pain. 
Toomingas (52) * 1999 Middle-age workers Symmetrical neck and shoulder pain 
distribution are characterized based on 
duration and severity. 
Sanders, Mann     
(67) # § 
2000  An artificial neural network can 
subgroup pain drawings based on 
dermatomes. 
Türp, Kowalski, 
Stohler (237) * 
2000 Female patients with 
temporomandibular 
pain 
Generic pain intensity ratings may 
provide a better picture than site-
specific intensity ratings. 
Ghinea et al.     
(238) * § 
2002  Geographical information systems are 
proposed as a method to visualize and 
analyze pain drawings. 
Gagliese, 
Melzack (239) 
2003 Patients with chronic 
pain  
Age differences are identified in the 
selection of pain quality descriptors. 
Bertilson, 
Grunnesjö, 
Strender (240) * 
2003 Patients with neck and 
shoulder pain 
Some clinical tests may not be reliable. 
Knowledge of the medical history, 
including pain drawings, may improve 
the prevalence of clinical findings. 
Masferrer, 
Prendergast, 
Hagell (51) * 
2003 Patients with neck, 
low-back or radicular 
referred pain 
Colored pain drawings are as useful as 
black and white drawings. 
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North et al.   
(241) # 
2003 Patients with spinal 
cord stimulator 
Automated and self-adjustable spinal 
cord stimulators are more effective and 





2004 Patients with chronic 
pain 
A computerized pain assessment 
program can identify differences in pain 
intensity and location among patients 
and health individuals. 
Hwang et al.     
(243)  ¤ 
2005 Healthy participants Experimentally evoked referred pain 
patterns resemble dermatomes. 




Wheelchair users may benefit from 
using visual analogues scales and pain 
drawings to assess their pain. 
Slipman et al.   
(245) ¤ 





2006 Healthy participants Experimentally evoked local and 




2006 Patients with 
osteoporotic vertebral 
fractures 
The pain location may be misleading 
towards the location of the fracture. 
Carnes et al. 
(248) 
2007 General population     
in the UK 
Chronic pain located in a single site is 
less common than multi-site location. 
Linder, Svensson 
(249) 
2007 Long-term sick-listed 
patients 
A combination of depression severity 
and pain extent can be a useful to assess 
rehabilitation needs. 
Ghinea et al.       
(62) * # 
2008  Development of 3-D pain drawings 
Thompson et al. 
(250) * 
2009 Patients with chronic or 
frequent knee pain 
Knee pain can be location can differ, 
suggesting a variety of pain sources. 
McClish et al 
(251) 
2009 Patients with sickle cell 
disease 
Pain sites and location vary in frequency 
by age. 
ASSESSMENT OF SPATIOTEMPORAL CHANGES OF PAIN AND SENSORY PERCEPTIONS                                      




2009 Patients with chronic 
pain 
Quantification of the pain area using a 
computerized assessment of pain 
drawings. 
Felix et al. (252) 2010 Patients referred for 
spinal surgery 
Quantitative computerized pain 
drawings can be a useful clinical tool. 
Jud et al. (253) # 2010 Breast cancer survivors Body charts with a breast outline can 




2011 Patients with chronic 
pain 
Good intra-rater reliability of a 
computer-aided pain area quantification. 
Elson et al.   
(255) # 
2011 Patients with knee pain Development and validation of a 
photographic knee pain map. 
Jamison et al. 
(64) * 
2011 Patients with chronic 
pain 
Three-dimensional pain mapping is a 
reliable method to report pain location. 
Alonso-Blanco et 
al. (256) § 
2012 Female patients with 
myofascial 
temporomandibular 
pain and fibromyalgia 
syndrome 
Identification of differences in the 
location of areas of referred pain. 
Egloff et al.  
(180) § 
2012 Patients with 
somatoform-functional 
pain 
Identification of drawing criteria to use 
pain drawings as a screening tool. 
Pierce et al.  
(257) # 
2012 Pregnant women High prevalence of lumbo-pelvic pain. 
Renner et al. 
(258)  
2012 Patients with 
endometriosis 
Development of endometriosis pain 
maps. 
Chatterton et al. 
(259) 
2013 Patients with foot pain Reliable repeatability scores of foot pain 
drawings. 
Prins, van der 
Wurff, Groen 
(132) 
2013 Patients with chronic 
low-back pain with and 
without referred leg 
pain 
Patients with referred leg pain have 
more intense pain, higher disability 




Jaatun et al (63) # 2013 Patients with advanced-
stage cancer 
iPad-based pain assessment has better 
results than pen-to-paper and laptop-
based assessments. 
Southerst et al.  
(260) # 
2013 Patients with whiplash-
associated disorders 
Good inter-examiner reliability of pain 
drawings acquired from pen-to-paper 
and electronic body charts. 
Gerhardt et al. 
(140) 
2014 General population in 
Germany 
Patients with chronic back pain may 
also have pain sites located outside the 
back. 
Gumina et al. 
(261) 
2014 Patients with postero-
superior rotator cuff 
tear 
Development of pain distribution maps 
for rotator cuff tears. 
Spyridonis et al. 
(201) * 
2014 Wheelchair users and 
clinicians 
Development of a virtual reality 
application for the assessment of pain. 
Tucker et al. 
(262) * 
2014 Healthy participants Description of experimentally evoked 
pain intensity, location, depth, and 
quality in different low-back muscles. 
Barmettler et al. 
(263) 
2015 Patients with migraine 
headaches 
Description of spatiotemporal pain 
patterns and quality descriptors. 




Identification of two different pain 
pattern phenotypes. 
Barbero et al. (75) 2015 Patients with chronic 
back and neck pain 
Digital pain drawings have a good test-
retest reliability. 
Jaatun et al.    
(71) # 
2015 Patients with advanced-
stage cancer 
Development of a web-based pain 
drawing solution, as well as design 
guidelines for software development.  
Torstesson et al. 
(265) 
2015 Female patients with 
chronic pelvic pain 
Description of referred pain patterns. 
Van Hecke et al. 
(266) 
2015  Consensus for neuropathic pain 
phenotyping. 
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Boudreau et al. 
(61) 
2016 Patients with chronic 
neck pain 
Touchscreen acquired pain drawings are 
as reliable as pen-to-paper. Three-
dimensional body charts are more 
accurate than 2-D. 
Tesarz et al. (42) 2016 Patients with chronic 
low-back pain 
Description of the stable or spread of 
pain extent over time. 
Van Ginckel et al 
(267) 
2016 Patients with medial 
tibiofemoral 
osteoarthritis 
Diffuse pain location associated with 
more severe and physical dysfunction 
than pain isolated to the medial aspect 
Hawkins et al. 
(268) 
2016 Patients with orofacial 
pain 
Patients report multiple pain sites 
outside the orofacial area. 
Lluch Girbés et 
al. (127) 
2016 Pre-operative patients 
with knee osteoarthritis 
Widespread pain distribution is 
associated with some central 
sensitization signs. 
Falla et al. (269) 2016 Patients with whiplash-
associated disorders 
Widespread pain extent is associated 
with disability, depression, and self-
efficacy. 
Egsgaard et al.    
(74) * # 
2016 Female patients with 
chronic pain 
Gender-specific body charts may 
facilitate more accurate pain 
communication. 
Poulsen et al. 
(270) 
2016 Patients with hip 
osteoarthritis 
Description of common pain 
distribution. 
Zhang et al.   
(271) § 
2016 Datasets from multiple 
patients 
Assessment of machine learning 
methods for diagnosis prediction. 
Barbero et al. 
(144) 
2017 Female patients with 
fibromyalgia syndrome 




Rathleff (76) § 
2017 Patients with 
patellofemoral pain 
Identification of symmetrical and non-
symmetrical pain distribution patterns. 
Candela et al. 
(272) 
2017 Patients with adhesive 
capsulitis 




Cruder et al. (18) 2018 Musicians High prevalence of pain, and correlation 
between pain extent and disability. 
Doménech-García 
et al. (117) 
2018 Pain-free patients 
recovering from a 
shoulder fracture 
Pressure-induce pain is larger in patients 
recovering from fracture than in healthy 
participants. 
Boudreau et al. 
(20) § 
2018 Patients with 
patellofemoral pain 
Identification of distinct Anchor, hook, 
and ovate pain distribution patterns. 
Rio et al. (273) 2018 Australian rules 
football players 
Self-reported pain drawings are more 
reliable than clinician pain drawings. 
Neubert et al. 
(274) 
2018 Chronic pain patients 
and clinicians 
Development, evaluation, and usability 
of a tablet-based software app to acquire 
pain drawings and related symptoms. 
Shaballout et al. 
(19) §  
2018 Patients in acute pain Electronic pain drawings can improve 
the patient-clinician communication. 
Wallace et al. 
(275) § 
2018 Patients with chronic 
pain 
Development of a pain drawing 
compound score. 
Swinnen et al. 
(276) 
2018 Patients with axial 
spondyloarthritis 
Females are more likely to report 
widespread pain than men. 
Riis et al. (131) 2019 Patients with chronic 
neck pan 
Pain extent is associated with disability, 
depression, and clinical tests. 
Fernández-de-las-
Peñas et al. (277) 
2019 Female patients with 
carpal tunnel syndrome 
Pain extent is not associated with 
physical or psychological variables. 
Caseiro et al. (70) 2019 Patients and clinicians Clinicians have a good reliability to 
reproduce pen-to-paper pain to digital 
pain drawings. 
Galve Villa et al. 
(77) * # ¤ 
2020 Healthy participants Self-adjustable animations may be a 
useful tool to quantify changes in 
quality descriptors. 
Galve Villa et al. 
(143) #  
2020 Participants with 
chronic non-malignant 
spinally referred pain 
The pain and discomfort intensity and 
extent fluctuate as captured remotely 
over a prolonged period.  
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